Other superficial mycoses, including avohilmo

AB1_OTHER_SUPERF_MYCOSIS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — B36 Hospital discharge: ICD-10 — B36 Hospital discharge: ICD-9 — 111 Hospital discharge: ICD-8 — 111 Cause of death: ICD-10 — B36 Cause of death: ICD-9 — 111 Cause of death: ICD-8 — 111 3 out of 7 registries used, show all original rules.	5581
4. Check minimum number of events None	5581
5. Include endpoints None	5581
6. Filter based on genotype QC (FinnGen only)	4938

Control definitions (FinnGen only)

Control exclude: AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF13

NAME	AB1_OTHER_SUPERF_MYCOSIS_WIDE
CONTROL_EXCLUDE	AB1_MYCOSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	B36
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B36
HD_ICD_9	111
HD_ICD_8	111
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B36
COD_ICD_9	111
COD_ICD_8	111
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other superficial mycoses, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Other superficial mycoses

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4938	2951	1987
Unadjusted period prevalence (%)	0.99	1.05	0.91
Median age at first event (years)	47.88	44.51	52.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5254: Matched controls
52540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B36

ICD-10 Finland

Other superficial mycoses

+∞

307.7

363

B36.9

ICD-10 Finland

Superficial mycosis, unspecified

+∞

307.7

572

J02AC02

ATC

itraconazole; systemic

4.2

307.7

1562

4804

B36.0

ICD-10 Finland

Pityriasis versicolor

+∞

307.7

3494

B36.8

ICD-10 Finland

Other specified superficial mycoses

+∞

307.7

771

J02AB02

ATC

ketoconazole; oral

7.2

234.9

364

541

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.4

163.3

1414

6865

D01BA02

ATC

terbinafine; oral

2.3

142.9

1449

7475

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.2

130.4

1429

7568

J02AC01

ATC

fluconazole; systemic

1.9

111.8

2224

14469

S29

ICPC

Skin symptom/complaint other

2.1

108.8

1246

6650

B35.3

ICD-10 Finland

Tinea pedis

3.1

73.5

332

1135

B35.4

ICD-10 Finland

Tinea corporis

5.7

72.5

135

240

B35.1

ICD-10 Finland

Tinea unguium

2.6

66.4

409

1647

S21

ICPC

Skin texture symptom/complaint

2.0

63.2

833

4584

S74

ICPC

Dermatophytosis

4.1

62.3

173

430

D01AC02

ATC

miconazole; topical

2.5

58.9

381

1569

M79.6

ICD-10 Finland

Pain in limb

1.6

56.9

2282

17074

D01AE15

ATC

terbinafine; topical

2.5

54.8

357

1474

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

54.8

1658

11564

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

54.3

3206

26117

B37.08

ICD-10 Finland

Other candidal stomatitis

8.6

52.4

L17

ICPC

Foot/toe symptom/complaint

1.6

51.1

1537

10665

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

3.9

50.1

148

385

E0000UV, ,

ATC

1.5

48.2

2174

16507

Z71.8

ICD-10 Finland

Other specified counselling

1.5

46.9

1925

14295

D01AE16

ATC

amorolfine; topical

2.1

46.5

493

2495

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

45.2

1974

14822

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.5

44.6

288

1183

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

44.2

1061

6918

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

44.0

1509

10725

M25.5

ICD-10 Finland

Pain in joint

1.5

43.3

1725

12670

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

41.2

459

2362

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

40.8

785

4809

D07AC01

ATC

betamethasone; topical

1.5

40.0

1713

12729

Z01.7

ICD-10 Finland

Laboratory examination

1.7

38.5

892

5741

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

35.8

1368

9875

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

35.4

384

1955

S08

ICPC

Skin colour change

2.3

35.3

272

1209

S18

ICPC

Laceration/cut

1.4

35.1

2109

16639

M54.5

ICD-10 Finland

Low back pain

1.5

34.7

1884

14572

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

34.7

888

5845

S02

ICPC

Pruritus

2.5

34.6

232

969

Z2221

NOMESCO Finland

Medical doctor

1.5

33.5

1289

9298

J20

ICD-10 Finland

Acute bronchitis

1.8

33.4

533

3081

Z01.2

ICD-10 Finland

Dental examination

1.4

32.7

2563

21117

A02BC02

ATC

pantoprazole; systemic

1.4

32.6

3089

26313

D22

ICD-10 Finland

Melanocytic naevi

2.0

32.1

373

1944

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

31.7

1175

8392

R06.0

ICD-10 Finland

Dyspnoea

1.5

31.6

1137

8071

R4110

NOMESCO Finland

Physiotherapy

1.5

31.4

1200

8623

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

31.4

1403

10407

M01AH05

ATC

etoricoxib; oral

1.4

31.3

2990

25415

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

31.1

1052

7364

SDA03

NOMESCO Finland

Periodontal treatment

1.4

30.6

2169

17493

R42

ICD-10 Finland

Dizziness and giddiness

1.5

30.2

964

6661

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

29.9

680

4334

N76.0

ICD-10 Finland

Acute vaginitis

1.8

29.9

467

2681

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

29.6

3878

34674

J01DB01

ATC

cefalexin; oral

1.5

29.6

4207

38221

M03BX02

ATC

tizanidine; oral

1.4

29.3

3020

25869

J45

ICD-10 Finland

Asthma

1.7

29.1

533

3203

H62.2*B36.9

ICD-10 Finland

Otomycosis NOS

57.0

29.1

R53

ICD-10 Finland

Malaise and fatigue

1.5

28.6

1270

9378

M54

ICD-10 Finland

Dorsalgia

1.6

28.2

707

4612

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

28.0

1037

7380

D07AD01

ATC

clobetasol; topical

1.6

28.0

721

4732

R06AX27

ATC

desloratadine; oral

1.4

28.0

1587

12256

R03AC02

ATC

salbutamol; inhalant

1.4

27.9

2715

22955

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

27.8

539

3290

A97

ICPC

No disease

1.5

27.6

1014

7206

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.0

27.2

117

R01AD09

ATC

mometasone; nasal

1.4

27.2

2327

19239

Z3226

NOMESCO Finland

Physiotherapist

1.6

27.1

765

5130

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

26.9

551

3412

L80

ICD-10 Finland

Vitiligo

5.7

26.7

R52.9

ICD-10 Finland

Pain, unspecified

1.7

26.6

506

3070

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.5

26.2

1097

7990

EB1AA, ,

SPAT

1.9

26.1

353

1935

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

26.1

1396

10646

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

26.0

852

5902

D07AC13

ATC

mometasone; topical

1.4

25.3

1282

9669

H02AB06

ATC

prednisolone; systemic

1.4

25.2

2062

16859

U13

ICPC

Bladder symptom/complaint other

2.6

24.8

146

574

U07

ICPC

Urine symptom/complaint other

1.8

24.7

368

2078

D11

ICPC

Diarrhoea

1.6

24.7

705

4731

L42

ICD-10 Finland

Pityriasis rosea

3.9

24.6

191

M01AB05

ATC

diclofenac; systemic, rectal

1.4

24.6

3048

26521

D01AC03

ATC

econazole; topical

2.1

24.6

243

1194

R51

ICD-10 Finland

Headache

1.9

24.5

346

1923

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

24.5

868

6107

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

24.4

444

2660

N02AX02

ATC

tramadol; systemic, rectal

1.4

24.4

1763

14113

R74

ICPC

Upper respiratory infection acute

1.4

24.3

2004

16374

R01AD58

ATC

fluticasone, combinations; nasal

1.4

24.2

1403

10822

M01AE02

ATC

naproxen; oral, rectal

1.3

24.2

2843

24511

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

24.1

2100

17299

L15

ICPC

Knee symptom/complaint

1.4

24.1

1143

8509

M79.1

ICD-10 Finland

Myalgia

1.5

24.0

787

5443

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

24.0

251

1259

A07AA02

ATC

nystatin; oral

2.2

24.0

211

991

D19

ICPC

Teeth/gum symptom/complaint

1.4

23.9

1656

13156

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

23.8

615

4030

R51.80

ICD-10 Finland

Headache

1.5

23.8

861

6079

G44.2

ICD-10 Finland

Tension-type headache

1.5

23.8

712

4828

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

23.7

1041

7637

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

23.6

3693

33204

B37.2

ICD-10 Finland

Candidiasis of skin and nail

4.7

23.5

116

R05

ICD-10 Finland

Cough

1.5

23.4

996

7260

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.7

23.4

410

2431

J01AA02

ATC

doxycycline; systemic

1.4

23.3

3503

31259

A02BC05

ATC

esomeprazole; systemic

1.4

23.3

1697

13579

L01

ICPC

Neck symptom/complaint

1.5

23.2

845

5972

A98

ICPC

Health maint/preventive medicine

2.8

23.2

5159

49980

D01

ICPC

Abdominal pain/cramps general

1.5

23.0

693

4704

G47.3

ICD-10 Finland

Sleep apnoea

1.4

22.6

992

7269

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

22.6

1850

15057

K30

ICD-10 Finland

Functional dyspepsia

1.6

22.5

538

3458

L28

ICPC

Limited function/disability (L)

1.6

22.4

643

4317

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

22.3

3745

33863

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

22.0

2061

17092

11100

ICD-8 Finland

Dermatomycosis, other and unspecified, Pityriasis versicolor

+∞

21.9

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

21.9

1518

12024

R12

ICD-10 Finland

Heartburn

1.7

21.8

426

2602

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

21.7

2747

23771

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

21.6

1633

13101

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

21.4

626

4218

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

21.2

1816

14838

WX110, ,

SPAT

1.8

21.1

311

1750

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.4

20.9

150

647

SFA20

NOMESCO Finland

Two-surface restoration

1.3

20.8

3014

26514

A04

ICPC

Weakness/tiredness general

1.5

20.7

794

5657

L30

ICD-10 Finland

Other dermatitis

2.4

20.7

147

632

N02BE01

ATC

paracetamol; systemic, rectal

1.4

20.6

4368

40687

H81

ICPC

Excessive ear wax

1.5

20.5

645

4411

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

20.4

1030

7725

J01FF01

ATC

clindamycin; systemic

1.4

20.3

1154

8828

U02

ICPC

Urinary frequency/urgency

1.5

20.3

649

4455

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

20.3

640

4381

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

20.3

1156

8850

H01

ICPC

Ear pain/earache

1.5

20.3

661

4557

B35

ICD-10 Finland

Dermatophytosis

3.9

20.2

153

M02AA07

ATC

piroxicam; topical

1.4

20.2

1264

9825

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

20.1

471

3010

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.8

20.1

287

1600

ZXE00

NOMESCO Finland

One hour or less

1.3

20.1

1702

13859

A01AB09

ATC

miconazole; local oral

1.8

20.1

326

1889

J01FA10

ATC

azithromycin; systemic

1.3

20.1

2985

26290

L30.8

ICD-10 Finland

Other specified dermatitis

2.3

20.0

150

660

L84

ICD-10 Finland

Corns and callosities

2.3

20.0

153

679

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

19.9

2648

22955

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

19.9

1381

10909

N06AX11

ATC

mirtazapine; oral

1.3

19.6

1530

12298

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

19.6

306

1753

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.0

19.6

218

1119

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.7

19.5

102

378

L08

ICPC

Shoulder symptom/complaint

1.4

19.5

995

7468

F29

ICPC

Eye symptom/complaint other

1.6

19.5

504

3299

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

19.3

1923

16001

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

19.3

1514

12172

H29

ICPC

Ear symptom/complaint other

1.6

19.1

518

3427

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

19.1

1625

13218

H60

ICD-10 Finland

Otitis externa

1.8

19.1

292

1663

H02AB07

ATC

prednisone; oral

1.6

19.1

500

3283

N03AX16

ATC

[U] pregabalin

1.4

19.0

874

6435

L30.0

ICD-10 Finland

Nummular dermatitis

2.1

19.0

178

857

J01MA02

ATC

ciprofloxacin; systemic

1.3

19.0

1511

12166

R03BA02

ATC

budesonide; inhalant

1.4

18.9

803

5827

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

18.8

741

5300

R07.3

ICD-10 Finland

Other chest pain

1.6

18.8

446

2858

L03

ICPC

Low back symptom/complaint

1.3

18.8

1437

11502

K02.1

ICD-10 Finland

Caries of dentine

1.3

18.7

3161

28186

R60.0

ICD-10 Finland

Localized oedema

1.6

18.1

458

2982

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

18.1

1846

15377

K03.66

ICD-10 Finland

Tooth plaque

1.7

18.0

377

2342

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

18.0

4674

44322

S76

ICPC

Skin infection other

1.9

18.0

235

1274

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

17.9

216

1140

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

17.9

1031

7884

N05BA04

ATC

oxazepam; oral

1.4

17.8

1139

8857

R06AE07

ATC

cetirizine; oral

1.3

17.7

2155

18363

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

17.6

1500

12172

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

17.5

392

2478

N48.1

ICD-10 Finland

Balanoposthitis

2.3

17.3

131

579

R02

ICPC

Shortness of breath/dyspnoea

1.5

17.3

553

3792

N01

ICPC

Headache

1.4

17.3

716

5168

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.4

17.1

118

501

N30

ICD-10 Finland

Cystitis

1.6

17.0

410

2638

S75

ICPC

Moniliasis/candidiasis skin

4.2

17.0

109

S06

ICPC

Rash localized

1.8

16.9

241

1343

Z3231

NOMESCO Finland

Registered nurse

1.4

16.8

1111

8673

X58

ICD-10 Finland

Exposure to other specified factors

1.4

16.8

751

5493

R03DC03

ATC

montelukast; oral

1.4

16.8

751

5494

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

16.7

489

3288

11199

ICD-8 Finland

Dermatomycosis, other and unspecified, Unspecified

+∞

16.7

L12

ICPC

Hand/finger symptom/complaint

1.4

16.6

843

6303

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

16.6

354

2208

B37.0

ICD-10 Finland

Candidal stomatitis

3.3

16.6

185

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

16.6

1149

9032

P01AB01

ATC

metronidazole; oral, rectal

1.3

16.6

1744

14540

R11

ICD-10 Finland

Nausea and vomiting

1.6

16.5

413

2680

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

16.4

598

4210

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

16.2

1735

14486

D12

ICPC

Constipation

2.1

16.1

149

715

S04

ICPC

Lump/swelling localized

1.5

16.0

542

3759

SBA00

NOMESCO Finland

Microbiological examinations

2.4

16.0

107

449

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

15.9

1062

8295

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.0

15.8

222

A28

ICPC

Limited function/disability NOS

1.5

15.8

493

3361

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

15.8

401

2612

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

15.7

808

6050

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

15.7

343

2153

H01.0

ICD-10 Finland

Blepharitis

1.6

15.7

357

2264

SFA10

NOMESCO Finland

One-surface restoration

1.3

15.6

2826

25140

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

15.5

292

1763

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

15.5

440

2937

R03BB04

ATC

tiotropium bromide; inhalant

1.7

15.5

298

1810

A11

ICPC

Chest pain NOS

1.6

15.5

332

2074

N17

ICPC

Vertigo/dizziness

1.5

15.5

511

3524

H92.0

ICD-10 Finland

Otalgia

1.6

15.4

346

2186

J01CA04

ATC

amoxicillin; systemic

1.3

15.4

4254

39903

H60.8

ICD-10 Finland

Other otitis externa

2.0

15.4

161

810

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

15.4

872

6637

R35

ICD-10 Finland

Polyuria

1.8

15.3

247

1429

C05AA08

ATC

fluocortolone; rectal, topical

1.5

15.3

480

3274

R01AD08

ATC

fluticasone; nasal

1.3

15.3

1341

10885

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

15.3

122

553

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.4

15.2

103

434

WX290

NOMESCO Finland

Other blockage of nerve

1.3

15.1

2626

23208

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

15.1

574

4069

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

15.1

203

1112

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

15.1

921

7091

D06

ICPC

Abdominal pain localized other

1.5

15.1

449

3030

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.8

15.0

216

1208

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.2

15.0

119

538

L60.0

ICD-10 Finland

Ingrowing nail

1.8

14.9

235

1350

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

14.9

148

730

J01FA09

ATC

clarithromycin; systemic

1.3

14.9

1382

11296

L16

ICPC

Ankle symptom/complaint

1.5

14.9

586

4181

L13

ICPC

Hip symptom/complaint

1.4

14.9

683

5012

R05

ICPC

Cough

1.3

14.9

1168

9332

A01

ICPC

Pain general/multiple sites

1.5

14.9

422

2818

N06AX21

ATC

duloxetine; oral

1.5

14.8

528

3695

S88

ICPC

Dermatitis contact/allergic

2.3

14.8

110

483

EB1SA, ,

SPAT

1.7

14.8

275

1655

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

14.7

222

1260

S22

ICPC

Nail symptom/complaint

1.7

14.6

295

1815

U01

ICPC

Dysuria/painful urination

1.6

14.6

362

2343

A06AC51

ATC

ispaghula, combinations; oral

1.9

14.6

184

987

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

14.5

443

3006

B35.8

ICD-10 Finland

Other dermatophytoses

5.4

14.5

S01

ICPC

Pain/tenderness of skin

1.8

14.5

206

1149

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

14.5

136

658

M01AH01

ATC

celecoxib; oral

1.4

14.4

588

4223

I84

ICD-10 Finland

Hemorrhoids

2.2

14.4

114

515

N05AH04

ATC

quetiapine; oral

1.4

14.3

879

6766

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

14.3

229

1322

R01AD12

ATC

fluticasone furoate; nasal

1.3

14.2

1618

13561

L02

ICPC

Back symptom/complaint

1.5

14.2

536

3792

N05BA01

ATC

diazepam; systemic, rectal

1.5

14.1

485

3369

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

14.1

834

6383

J05AB11

ATC

valaciclovir; oral

1.4

14.1

607

4405

H57.1

ICD-10 Finland

Ocular pain

1.8

14.0

208

1175

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

14.0

405

2717

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

13.9

2260

19745

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

13.9

348

2260

GD1AA, ,

SPAT

1.4

13.8

855

6591

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

13.7

780

5928

P01

ICPC

Feeling anxious/nervous/tense

1.4

13.7

870

6726

R07.0

ICD-10 Finland

Pain in throat

1.5

13.7

408

2752

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

13.7

1157

9327

L30.4

ICD-10 Finland

Erythema intertrigo

2.8

13.6

253

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

13.6

238

1410

H10

ICD-10 Finland

Conjunctivitis

1.5

13.6

403

2716

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

13.5

417

2833

M01AC01

ATC

piroxicam; systemic, rectal

1.5

13.5

407

2752

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

13.5

501

3536

G04BD12

ATC

mirabegron; oral

1.6

13.4

356

2342

U72

ICPC

Urethritis

2.2

13.4

110

505

K08.80

ICD-10 Finland

Toothache NOS

1.5

13.4

452

3131

H02

ICPC

Hearing complaint

1.5

13.3

469

3274

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

13.3

375

2500

S82

ICPC

Naevus/mole

1.4

13.2

658

4894

Z04

ICD-10 Finland

Examination and observation for other reasons

2.6

13.2

286

N05CF01

ATC

zopiclone; oral

1.3

13.2

1149

9294

D07AB08

ATC

desonide; topical

1.5

13.2

466

3257

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

13.2

1720

14631

B07.9

ICD-10 Finland

Verruca simplex

1.8

13.1

190

1065

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

13.1

1035

8255

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

13.1

481

3384

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

13.1

308

1969

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

13.1

545

3928

A02BC01

ATC

omeprazole; systemic

1.3

13.1

1016

8089

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

13.0

671

5017

WX002

NOMESCO Finland

Sedation and analgesia

1.4

13.0

672

5026

D09

ICPC

Nausea

1.6

13.0

283

1775

A46

ICD-10 Finland

Erysipelas

1.5

13.0

487

3440

A08

ICPC

Swelling

1.8

13.0

194

1098

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

13.0

385

2594

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

12.8

1011

8064

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

12.8

350

2318

R00.2

ICD-10 Finland

Palpitations

1.5

12.8

373

2506

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

12.8

507

3622

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

12.7

640

4765

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.3

12.7

1223

10012

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

12.7

422

2913

N06AX16

ATC

venlafaxine; oral

1.4

12.7

685

5162

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

12.7

439

3055

D07XC01

ATC

betamethasone; topical

1.5

12.7

438

3047

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

12.6

388

2636

H13

ICPC

Plugged feeling ear

1.4

12.6

697

5273

Z00.8

ICD-10 Finland

Other general examinations

1.5

12.5

371

2499

1110A

ICD-9 Finland

Dermatomycosis, other and unspecified, Pityriasis versicolor

+∞

12.5

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

12.5

359

2403

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

12.4

350

2334

E66

ICD-10 Finland

Obesity

1.6

12.3

278

1762

EBA00, ,

SPAT

2.0

12.2

125

625

A02BC03

ATC

lansoprazole; oral

1.3

12.2

971

7750

UKC02

NOMESCO Finland

Cystoscopy

1.4

12.1

465

3300

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

12.1

230

1395

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

12.1

148

788

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

12.1

299

1936

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

12.1

2802

25299

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.4

12.0

348

R25.2

ICD-10 Finland

Cramp and spasm

2.1

12.0

107

508

L57.0

ICD-10 Finland

Actinic keratosis

1.6

11.9

263

1657

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

11.9

830

6499

A23

ICPC

Risk factor NOS

1.4

11.8

497

3585

N30.0

ICD-10 Finland

Acute cystitis

1.4

11.8

719

5515

J01FA06

ATC

roxithromycin; oral

1.3

11.8

1581

13445

L04AX03

ATC

methotrexate; systemic

1.5

11.8

388

2672

R03AC03

ATC

terbutaline; inhalant

1.4

11.7

577

4279

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

11.7

254

1593

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

11.7

313

2063

A99

ICPC

Disease/condition unspecnature/site

1.5

11.7

424

2977

R13

ICD-10 Finland

Dysphagia

1.6

11.6

248

1550

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

11.6

409

2857

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

11.6

437

3092

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

11.5

372

2552

M54.8

ICD-10 Finland

Other dorsalgia

1.7

11.5

206

1230

R83

ICPC

Respiratory infection other

1.3

11.5

1454

12280

D06BB10

ATC

imiquimod; topical

1.7

11.5

215

1299

B36.2

ICD-10 Finland

White piedra

+∞

11.5

N05CF02

ATC

zolpidem; oral

1.4

11.5

695

5329

Z2446

NOMESCO Finland

Social worker

1.6

11.4

285

1851

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

11.4

1962

17138

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.5

11.3

290

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

11.3

358

2445

R30.0

ICD-10 Finland

Dysuria

1.7

11.3

203

1213

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

11.3

177

1018

D01AA02

ATC

natamycin; topical

2.3

11.3

390

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

11.3

1037

8426

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

11.2

787

6162

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

11.2

928

7435

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

11.2

220

1346

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

11.2

1266

10551

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

11.2

346

2354

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

11.2

469

3384

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.5

11.2

328

2207

M75.8

ICD-10 Finland

Other shoulder lesions

1.8

11.1

177

1024

-1, ,

NOMESCO Finland

1.2

11.0

1676

14432

D10

ICPC

Vomiting

1.5

11.0

364

2510

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

11.0

369

2552

S97

ICPC

Chronic ulcer skin

1.7

11.0

186

1094

J05AB01

ATC

aciclovir; systemic

1.3

11.0

893

7138

R5110, ,

SPAT

1.6

11.0

274

1779

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.7

10.9

178

1035

C07AA05

ATC

propranolol; systemic

1.3

10.9

923

7415

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

2.6

10.9

248

S20.2

ICD-10 Finland

Contusion of thorax

1.7

10.8

215

1319

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

10.8

379

2642

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

10.8

410

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

10.8

1412

11958

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

10.8

391

2746

R21

ICPC

Throat symptom/complaint

1.3

10.8

1269

10618

KMAK, ,

NOMESCO Finland

1.2

10.7

2482

22292

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.8

10.6

162

924

XQ848

NOMESCO Finland

Dermatological photography

2.0

10.6

110

553

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.9

10.6

138

750

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

10.6

1323

11142

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.6

10.5

220

1369

H02AB04

ATC

methylprednisolone; systemic

1.4

10.5

503

3712

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

10.5

448

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.6

10.5

243

1550

L85.3

ICD-10 Finland

Xerosis cutis

2.8

10.5

173

L09

ICPC

Arm symptom/complaint

1.6

10.4

226

1418

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

10.4

1100

9078

R23

ICD-10 Finland

Other skin changes

2.6

10.4

236

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

10.4

180

1066

T90

ICPC

Diabetes non-insulin dependent

1.3

10.3

747

5873

UJF32

NOMESCO Finland

Coloscopy

1.3

10.3

865

6937

K85

ICPC

Elevated blood pressure

1.4

10.3

511

3793

F32

ICD-10 Finland

Depressive episode

1.5

10.3

290

1934

H00.00

ICD-10 Finland

Hordeolum

1.6

10.3

226

1424

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

10.3

107

540

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

10.3

801

6362

L08.1

ICD-10 Finland

Erythrasma

8.8

10.2

L05

ICPC

Flank/axilla symptom/complaint

1.6

10.2

263

1719

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

1.9

10.2

117

610

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.7

10.2

202

1240

D02AE01

ATC

carbamide; topical

1.6

10.2

246

1585

G50.1

ICD-10 Finland

Atypical facial pain

2.3

10.1

319

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.1

512

3815

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

10.1

1228

10303

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

10.1

334

2305

L14

ICPC

Leg/thigh symptom/complaint

1.5

10.1

322

2206

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

10.0

992

8119

B37.04

ICD-10 Finland

Skin-mucous candidal stomatitis

8.4

10.0

R4120

NOMESCO Finland

Occupational therapy

1.6

10.0

255

1663

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

10.0

197

1207

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

1.9

10.0

124

664

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

10.0

156

897

L60

ICD-10 Finland

Nail disorders

2.9

9.9

156

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.9

1813

15870

D82

ICPC

Teeth/gum disease

1.2

9.9

1932

17021

XKD00

NOMESCO Finland

Uroflowmetry

1.4

9.8

422

3055

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

2.1

9.8

433

K07

ICPC

Swollen ankles/oedema

1.8

9.8

135

748

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

9.8

266

1761

S24

ICPC

Hair/scalp symptom/complaint other

2.5

9.7

232

C08CA01

ATC

amlodipine; oral

1.3

9.7

1134

9462

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

9.7

1054

8721

G01AA10

ATC

clindamycin; vaginal

1.4

9.6

551

4183

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

9.6

410

L30.3

ICD-10 Finland

Infective dermatitis

1.8

9.6

146

833

L20

ICD-10 Finland

Atopic dermatitis

1.7

9.6

183

1112

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

9.6

317

2185

J01CA08

ATC

pivmecillinam; oral

1.2

9.6

1702

14841

AA1AD

NOMESCO Finland

CT of head and brain

1.3

9.6

935

7636

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

9.6

247

1616

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.6

9.6

214

1355

D06BB04

ATC

podophyllotoxin; topical

1.5

9.5

277

1862

L86

ICPC

Back syndrome with radiating pain

1.6

9.5

241

1572

H93.1

ICD-10 Finland

Tinnitus

1.5

9.5

263

1750

L60.8

ICD-10 Finland

Other nail disorders

2.6

9.4

206

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.1

9.4

440

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

9.4

370

2636

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.6

9.4

212

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

9.4

280

1890

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

9.4

796

6385

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

9.3

180

1098

B35.9

ICD-10 Finland

Dermatophytosis, unspecified

2.6

9.3

190

S10

ICPC

Boil/carbuncle

1.5

9.3

257

1707

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

9.3

497

3732

N06AB04

ATC

citalopram; systemic

1.3

9.3

787

6314

M76.6

ICD-10 Finland

Achilles tendinitis

1.6

9.3

206

1302

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

9.3

568

4358

B86

ICD-10 Finland

Scabies

1.7

9.2

158

933

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

9.5

9.2

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

9.2

1046

8691

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.9

9.2

106

554

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

9.2

601

4651

L29

ICPC

Musculoskeletal sympt/complt other

1.4

9.2

349

2471

N06AB06

ATC

sertraline; oral

1.3

9.2

550

4203

C07AB07

ATC

bisoprolol; oral

1.2

9.2

1535

13292

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

9.2

162

965

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

9.2

445

3292

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

9.1

1142

9596

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

2.0

9.1

100

515

S06.0

ICD-10 Finland

Concussion

1.4

9.1

469

3503

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

9.1

216

1388

L50

ICD-10 Finland

Urticaria

1.9

9.1

102

530

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

9.0

247

1638

D23

ICD-10 Finland

Other benign neoplasms of skin

1.9

9.0

112

601

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

9.0

388

2811

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

9.0

344

2441

A01AB04

ATC

amphotericin B; local oral

1.9

9.0

117

638

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

9.0

260

P20

ICPC

Memory disturbance

1.5

9.0

304

2108

L04AB04

ATC

adalimumab; parenteral

1.9

8.9

113

611

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

8.9

606

4720

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

8.9

386

2802

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.6

8.9

180

1113

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

1.6

8.9

190

1191

K62.6

ICD-10 Finland

Ulcer of anus and rectum

2.5

8.9

207

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

8.8

193

1216

R06.5

ICD-10 Finland

Mouth breathing

1.4

8.8

367

2644

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.8

8.8

122

678

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

8.8

244

1623

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

8.6

8.8

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.8

8.8

134

767

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.3

8.8

519

3960

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

8.7

686

5446

A02BA02

ATC

ranitidine; systemic

1.3

8.7

560

4323

EBA00

NOMESCO Finland

Extraction of tooth

1.2

8.7

1753

15435

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

8.7

380

2759

K05.08

ICD-10 Finland

Another acute gingivitis

1.7

8.7

162

980

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

8.7

234

1547

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

8.7

212

1371

L29

ICD-10 Finland

Pruritus

2.1

8.7

354

D04

ICPC

Rectal/anal pain

2.2

8.7

341

L94.0

ICD-10 Finland

Localized scleroderma [morphea]

4.2

8.6

N06AX26

ATC

vortioxetine; oral

1.4

8.6

393

2877

N05CD07

ATC

temazepam; oral

1.5

8.6

283

1951

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

8.6

377

2741

K60.1

ICD-10 Finland

Chronic anal fissure

1.9

8.6

105

561

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

8.6

423

3136

B37

ICD-10 Finland

Candidiasis

4.8

8.6

N03AX12

ATC

[U] gabapentin; oral

1.3

8.6

561

4344

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

8.6

226

1488

M79.7

ICD-10 Finland

Fibromyalgia

1.7

8.5

146

863

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

8.5

159

962

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

8.5

275

1888

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

8.5

387

2830

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.5

8.5

250

1685

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

8.5

1937

17246

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

8.5

435

3246

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

8.4

126

717

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

8.4

155

935

U05

ICPC

Urination problems other

1.7

8.4

162

989

M75

ICD-10 Finland

Shoulder lesions

1.6

8.4

178

1113

K12.18

ICD-10 Finland

Other forms of stomatitis

3.0

8.4

116

L50.9

ICD-10 Finland

Urticaria, unspecified

1.6

8.4

183

1153

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

8.4

265

1813

J01EA01

ATC

trimethoprim; systemic

1.2

8.4

946

7852

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

8.3

335

2399

P06

ICPC

Sleep disturbance

1.3

8.3

619

4878

K59.0

ICD-10 Finland

Constipation

1.6

8.3

192

1226

U04

ICPC

Incontinence urine

1.6

8.3

167

1031

B02

ICD-10 Finland

Zoster [herpes zoster]

1.6

8.3

164

1009

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

8.3

285

1984

M15

ICD-10 Finland

Polyarthrosis

1.7

8.2

139

819

E66.8

ICD-10 Finland

Other obesity

1.5

8.2

246

1663

M01AX17

ATC

nimesulide; oral

1.3

8.2

698

5595

X15

ICPC

Vaginal symptom/complaint other

1.5

8.2

226

1501

M54.2

ICD-10 Finland

Cervicalgia

1.4

8.2

341

2456

M70.7

ICD-10 Finland

Other bursitis of hip

2.0

8.2

409

R96

ICPC

Asthma

1.4

8.2

375

2746

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.7

8.2

133

776

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

8.1

351

2545

J01CF05

ATC

flucloxacillin; systemic

1.4

8.1

301

2123

L29.0

ICD-10 Finland

Pruritus ani

2.4

8.1

222

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

8.1

199

1289

M02AA10

ATC

ketoprofen; topical

1.3

8.1

528

4087

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.1

3384

31696

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

8.1

492

3771

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

8.0

321

2296

H61.2

ICD-10 Finland

Impacted cerumen

1.5

8.0

251

1713

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

8.0

312

2221

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

8.0

352

2561

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

2.7

8.0

147

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

8.0

522

4040

JN1AE, ,

SPAT

1.6

8.0

191

1230

J01MA12

ATC

levofloxacin; systemic

1.3

8.0

583

4582

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

8.0

397

2948

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

8.0

147

888

Y25

ICPC

Fear sexually transm disease male

1.7

8.0

148

896

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

7.9

393

2916

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

7.9

579

4552

R52.0

ICD-10 Finland

Acute pain

1.7

7.9

152

928

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

7.9

160

990

T82

ICPC

Obesity

1.6

7.9

194

1258

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.9

358

2620

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

1.7

7.9

135

800

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.8

7.8

121

696

W19

ICD-10 Finland

Unspecified fall

1.4

7.8

365

2684

J01FA15

ATC

telithromycin; oral

1.4

7.8

353

2582

M48.0

ICD-10 Finland

Spinal stenosis

1.4

7.8

312

2234

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

7.8

232

1569

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

7.8

1130

9626

L10

ICPC

Elbow symptom/complaint

1.5

7.8

249

1709

SPAT1336

SPAT

Request for examination

1.7

7.7

126

736

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

7.7

1075

9115

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.6

7.7

195

1272

D02

ICPC

Abdominal pain epigastric

1.5

7.7

265

1843

G04CA02

ATC

tamsulosin; oral

1.3

7.7

598

4738

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

7.7

346

2527

SPF13

NOMESCO Finland

Fitting of the denture in the mouth in connection with the foundation of the loose prosthesis

3.1

7.7

101

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

7.7

281

1979

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.5

7.6

210

1396

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.3

7.6

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

1.7

7.6

126

739

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

7.6

125

732

R52

ICD-10 Finland

Pain, not elsewhere classified

2.2

7.6

280

X23

ICPC

Fear sexually transm dis female

1.4

7.6

356

2619

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.4

7.6

211

M77.4

ICD-10 Finland

Metatarsalgia

1.5

7.6

249

1718

K80

ICPC

Cardiac arrhythmia NOS

1.4

7.6

298

2127

J01DA06

ATC

[U] cefuroxime

1.3

7.6

533

4169

R30.1

ICD-10 Finland

Vesical tenesmus

2.0

7.6

401

ZXD35

NOMESCO Finland

Usual procedure

1.8

7.6

110

622

R04.2

ICD-10 Finland

Haemoptysis

1.8

7.6

535

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

7.6

478

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

7.5

156

971

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

7.5

288

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

7.5

317

2291

F03

ICPC

Eye discharge

1.4

7.5

301

2156

F51

ICD-10 Finland

Nonorganic sleep disorders

1.5

7.5

224

1517

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

7.5

292

2082

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.7

7.5

120

699

R03BA08

ATC

ciclesonide; inhalant

1.4

7.4

326

2371

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

7.4

291

2075

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.7

7.4

143

875

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

7.4

323

2348

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

7.4

225

1529

N76

ICD-10 Finland

Other inflammation of vagina and vulva

2.1

7.4

310

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

7.4

312

2257

P76

ICPC

Depressive disorder

1.4

7.3

357

2642

S63.4

ICD-10 Finland

Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)

1.9

7.3

490

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

7.3

385

S16

ICPC

Bruise/contusion

1.8

7.3

109

621

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.3

861

7169

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

7.3

1001

8469

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

1.8

7.3

111

636

L70

ICD-10 Finland

Acne

1.7

7.3

141

863

M67.4

ICD-10 Finland

Ganglion

1.4

7.3

286

2040

XX9XE

NOMESCO Finland

Other ultrasound examination

2.7

7.3

143

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

7.3

258

1806

11180

ICD-8 Finland

Dermatomycosis, other and unspecified, Erythrasma mycoides

+∞

7.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

7.3

805

6657

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.5

7.3

197

1306

NA3BG, ,

SPAT

1.5

7.3

197

1306

H66.9

ICD-10 Finland

Otitis media, unspecified

1.4

7.3

360

2673

J01DA01

ATC

[U] cefalexin

1.2

7.3

2692

24851

R50.9

ICD-10 Finland

Fever, unspecified

1.3

7.2

616

4938

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.4

7.2

344

2537

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

7.2

207

1389

N07CA01

ATC

betahistine; oral

1.5

7.2

195

1293

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

7.2

193

1277

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.5

7.2

192

1269

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.7

7.2

122

722

G43

ICD-10 Finland

Migraine

1.4

7.2

308

2234

Y04

ICPC

Penis symptom/complaint other

2.5

7.1

168

R4110, ,

SPAT

1.3

7.1

456

3518

R03AC13

ATC

formoterol; inhalant

1.6

7.1

155

977

K03.00

ICD-10 Finland

Approximal wear

1.4

7.1

349

2586

M45

ICD-10 Finland

Ankylosing spondylitis

1.9

7.1

459

F10.20

ICD-10 Finland

Alcohol dependence currently independent

1.9

7.1

417

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

7.1

802

6645

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

7.1

406

3082

L04AX01

ATC

azathioprine; systemic

1.6

7.1

163

1042

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

7.1

265

1876

T74.1

ICD-10 Finland

Physical abuse

1.8

7.1

104

591

D50

ICD-10 Finland

Iron deficiency anaemia

1.8

7.1

104

591

A02BX02

ATC

sucralfate; oral

1.8

7.1

540

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

7.1

138

848

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

7.1

657

5326

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.9

7.0

461

N05BE01

ATC

buspirone; oral

1.7

7.0

114

666

P17

ICPC

Tobacco abuse

2.1

7.0

316

R09.1

ICD-10 Finland

Pleurisy

1.9

7.0

412

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.5

7.0

179

1172

R03AC12

ATC

salmeterol; inhalant

1.7

7.0

127

765

ZXA05

NOMESCO Finland

Left side

1.2

7.0

748

6161

N03AE01

ATC

clonazepam; systemic

1.5

7.0

194

1294

M10

ICD-10 Finland

Gout

1.7

7.0

125

751

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

7.0

286

2058

PH2AE, ,

SPAT

1.8

7.0

535

J01MA01

ATC

ofloxacin; systemic

1.5

6.9

227

1566

R61

ICD-10 Finland

Hyperhidrosis

2.4

6.9

195

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

6.9

199

1337

ZA1.0

ICD-10 Finland

Shoulder region

1.9

6.9

471

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

6.9

115

677

N05AB03

ATC

perphenazine; systemic, rectal

1.7

6.9

130

791

N03AX09

ATC

lamotrigine; oral

1.5

6.9

239

1667

X14

ICPC

Vaginal discharge

1.6

6.9

138

853

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

6.9

387

R03BC03

ATC

nedocromil; inhalant

1.5

6.9

218

1494

N02BF01

ATC

gabapentin; oral

1.4

6.8

375

2829

XX1VW, ,

SPAT

2.6

6.8

148

J01DC02

ATC

cefuroxime; systemic

1.5

6.8

211

1439

H61.8

ICD-10 Finland

Other specified disorders of external ear

2.5

6.8

154

R52.2

ICD-10 Finland

Other chronic pain

1.6

6.8

140

871

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.7

6.8

110

642

K05.30

ICD-10 Finland

Periodontitis complex

1.3

6.8

534

4236

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

6.8

218

1498

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

6.8

405

3094

ZXD20

NOMESCO Finland

Day surgery

1.3

6.8

452

3509

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

6.8

207

1409

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

6.8

257

1824

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.2

6.8

261

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

6.8

393

2992

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

40.1

6.8

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.7

1545

13697

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.1

6.7

275

P58

ICPC

Psychological, Therapeutic counselling/listening

1.7

6.7

116

691

L01BA01

ATC

methotrexate; systemic

1.7

6.6

117

700

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

3.7

6.6

Z00.0

ICD-10 Finland

General medical examination

1.2

6.6

792

6604

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.6

6.6

150

957

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.6

6.6

145

DM1QA, ,

SPAT

1.5

6.6

226

1574

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.6

6.6

155

997

S22.3

ICD-10 Finland

Fracture of rib

1.4

6.6

244

1725

K05.0

ICD-10 Finland

Acute gingivitis

1.7

6.6

101

582

EB1HA, ,

SPAT

1.7

6.5

110

650

B08.1

ICD-10 Finland

Molluscum contagiosum

3.3

6.5

I50

ICD-10 Finland

Heart failure

2.1

6.5

278

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

6.5

492

3884

NH3AA, ,

SPAT

1.4

6.5

268

1931

P74

ICPC

Anxiety disorder/anxiety state

1.4

6.5

265

1906

ZXD05

NOMESCO Finland

Urgent procedure

1.2

6.5

1214

10570

L43.8

ICD-10 Finland

Other lichen planus

2.2

6.5

246

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.9

6.5

403

M77.0

ICD-10 Finland

Medial epicondylitis

1.7

6.5

109

645

J01MA06

ATC

norfloxacin; oral

1.3

6.4

394

3023

L29.8

ICD-10 Finland

Other pruritus

2.1

6.4

260

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.9

6.4

362

H60.3

ICD-10 Finland

Other infective otitis externa

1.8

6.4

535

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.4

1237

10801

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

6.4

522

4164

M19

ICD-10 Finland

Other arthrosis

2.0

6.4

356

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

6.4

767

6398

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

6.3

374

2854

N06AB10

ATC

escitalopram; oral

1.2

6.3

999

8560

SPF02

NOMESCO Finland

Impression for dental prosthesis repair, restricted

2.5

6.3

148

NH1BG, ,

SPAT

1.8

6.3

507

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.7

6.3

102

596

G04CA01

ATC

alfuzosin; oral

1.4

6.3

332

2490

B48.8

ICD-10 Finland

Other specified mycoses

5.2

6.3

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

6.3

367

2796

H02AB02

ATC

dexamethasone; systemic

0.7

6.3

180

2626

ZXA10

NOMESCO Finland

Bilateral

1.3

6.3

585

4741

R07

ICPC

Sneezing/nasal congestion

1.3

6.3

348

2631

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.4

6.3

313

2328

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

6.3

440

3440

L73.8

ICD-10 Finland

Other specified follicular disorders

2.1

6.3

256

Z30.8

ICD-10 Finland

Other contraceptive management

1.5

6.3

172

1146

S15

ICPC

Foreign body in skin

1.4

6.3

225

1582

C10AA05

ATC

atorvastatin; oral

1.2

6.3

1254

10980

11299

ICD-8 Finland

Moniliasis

+∞

6.2

K64

ICD-10 Finland

Haemorrhoids and perianal venous thrombosis

2.3

6.2

192

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

6.2

284

2082

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

6.2

117

713

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

6.2

323

2418

C03CA01

ATC

furosemide; systemic

1.2

6.2

682

5631

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.8

6.2

547

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.4

6.2

263

1905

UJH02

NOMESCO Finland

Anoscopy

1.6

6.2

129

807

D05AX52

ATC

calcipotriol, combinations; topical

1.5

6.2

178

1198

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

6.2

1296

11390

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

6.2

205

1420

SPAT1310

SPAT

Counselling related to known health issue

1.2

6.2

1319

11611

R41.3

ICD-10 Finland

Other amnesia

1.9

6.2

417

S80.0

ICD-10 Finland

Contusion of knee

1.4

6.2

329

2474

L29.2

ICD-10 Finland

Pruritus vulvae

1.9

6.2

410

A29

ICPC

General symptom/complaint other

1.3

6.1

476

3771

N06AX12

ATC

bupropion; oral

1.3

6.1

382

2938

J04.0

ICD-10 Finland

Acute laryngitis

1.5

6.1

186

1266

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

1.9

6.1

418

N63

ICD-10 Finland

Unspecified lump in breast

1.4

6.1

274

2003

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

6.1

256

1850

D01AC07

ATC

tioconazole; topical

1.8

6.1

535

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

6.1

550

EB1CA, ,

SPAT

2.4

6.1

157

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

6.1

210

1466

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

1.7

6.1

105

626

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

6.1

238

1701

K03.80

ICD-10 Finland

Irradiated enamel

1.4

6.1

248

1786

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.5

6.0

202

1401

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

6.0

307

2291

EJ2S1

NOMESCO Finland

Photography of oral mucosa

2.4

6.0

170

L92.0

ICD-10 Finland

Granuloma annulare

3.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000494) Fungus identified in Specimen by Culture

1148

5235

2.53

150.40

1.6

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2281

17569

1.53

46.93

2.3

2.0

97.14

97.20

pmol/l

0.02

1219

9663

(40768443) Skin Pathology biopsy report

385

1789

2.24

45.10

1.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3792

32734

1.57

44.61

5.1

4.1

9.44

9.83

mm/h

1.27

3573

30948

(3031040) Bacteria [#/volume] in Urine by Automated count

3429

29148

1.51

41.54

5.4

4.1

145.86

1336.22

e6/l

3.32

352

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4609

42005

1.79

41.31

6.0

5.2

1.75

1.80

mu/l

1.28

4362

39742

(3013115) Eosinophils [#/volume] in Blood

2927

24197

1.47

39.97

8.5

6.6

0.19

e9/l

1.07

2555

21424

(3006504) Eosinophils/Leukocytes in Blood

2636

21370

1.47

39.67

7.9

6.6

2.85

2.79

0.56

2456

20173

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2509

20156

1.47

39.51

2.7

2.4

74.31

73.90

nmol/l

0.31

2316

18766

(3022096) Basophils/Leukocytes in Blood

2633

21354

1.47

39.46

8.0

6.6

0.69

0.68

0.64

2453

20139

(3019069) Monocytes/Leukocytes in Blood

2635

21414

1.46

38.81

8.0

6.6

8.58

0.04

2457

20241

(3006315) Basophils [#/volume] in Blood

2837

23414

1.46

38.36

7.9

6.4

0.04

e9/l

0.04

2433

20402

(3007164) IgA [Mass/volume] in Serum or Plasma

1505

10962

1.52

38.23

1.5

2.18

2.25

g/l

1.03

923

7180

(3018010) Neutrophils/Leukocytes in Blood

2674

21835

1.46

38.14

7.7

6.4

56.31

56.60

0.72

2525

20995

(3001604) Monocytes [#/volume] in Blood

2830

23382

1.46

37.80

7.9

6.4

0.56

e9/l

0.10

2428

20376

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3991

35385

1.53

36.55

3.9

3.5

—

(3018095) Leukocytes [#/volume] in Urine

2085

16329

1.46

36.49

4.6

3.7

51.59

78.86

e6/l

1.73

1381

10982

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3730

32644

1.49

36.04

8.4

7.7

75.40

75.77

u/l

0.16

3547

31144

(3002030) Lymphocytes/Leukocytes in Blood

2697

22203

1.44

35.94

7.8

6.5

29.19

29.00

0.44

2548

21191

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1674

12597

1.48

35.79

1.4

1.71

1.64

u/ml

0.08

430

3634

(3019198) Lymphocytes [#/volume] in Blood

2882

24052

1.44

35.45

7.9

6.4

1.96

1.97

e9/l

0.05

2516

21476

(3013650) Neutrophils [#/volume] in Blood by Automated count

3068

25920

1.44

35.17

10.8

9.5

4.06

4.05

e9/l

0.17

2637

22613

(3014051) Protein [Presence] in Urine by Test strip

1797

13762

1.46

34.93

3.0

2.7

0.34

0.04

0.40

211

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4440

40500

1.62

34.14

6.2

5.2

37.99

37.93

mmol/mol

0.18

4210

38579

(3021960) Folate [Moles/volume] in Serum or Plasma

1475

10905

1.49

34.10

1.7

1.6

19.85

19.89

nmol/l

0.04

1282

9520

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4846

45293

1.90

33.87

16.8

13.1

20.47

22.20

mg/l

3.48

3978

36529

(3033658) Prothrombin time (PT) actual/Normal

1483

11008

1.48

33.49

4.2

4.0

93.06

92.45

0.47

1452

10764

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4038

36160

1.50

32.70

4.7

4.4

14.48

14.53

pmol/l

0.67

3746

33707

(3015736) pH of Urine

2405

19599

1.42

32.67

3.5

3.1

6.23

6.22

0.11

1267

11277

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

975

6709

1.56

31.20

3.2

2.9

3.70

3.04

e6/l

0.77

455

3105

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1038

7271

1.53

30.57

3.2

2.8

0.74

1.09

e6/l

3.17

525

3686

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1890

14942

1.41

29.60

3.8

3.2

—

2.34

—

(3026389) Candida sp identified in Specimen by Organism specific culture

165

634

2.65

29.30

1.4

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

1740

13630

1.41

28.43

3.8

3.1

27.77

87.34

e6/l

4.11

1278

10177

(3030467) Casts [#/volume] in Urine by Automated count

1535

11759

1.43

28.42

3.7

3.1

0.25

0.34

e6/l

1.63

1077

8407

(36304419) Bacteria [Presence] in Urine

1500

11460

1.43

28.13

3.6

3.0

0.33

71.54

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1317

9822

1.45

28.13

2.7

2.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4584

42549

1.61

28.11

14.9

12.2

90.52

90.15

ml/min/173m2

0.59

4206

38727

(3048689) Calprotectin [Mass/mass] in Stool

1015

7190

1.51

28.07

2.7

96.11

119.32

ug/g

2.33

796

5789

(3007853) Bacteria identified in Skin by Aerobe culture

782

5240

1.58

27.83

1.8

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1411

10679

1.44

27.80

2.8

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3765

33697

1.41

26.81

3.7

3.2

43.30

40.96

u/l

1.07

3600

32247

(3009261) Glucose [Presence] in Urine by Test strip

2862

24516

1.37

26.45

4.0

3.5

0.01

0.07

estimate

0.56

472

4913

(3021601) Nitrite [Presence] in Urine by Test strip

2821

24137

1.36

26.11

4.0

3.5

0.00

estimate

0.21

498

5086

(3011397) Hemoglobin [Presence] in Urine by Test strip

1415

10815

1.42

26.10

3.8

3.4

0.60

0.19

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2356

19600

1.37

26.07

7.0

6.9

1.21

mmol/l

1.01

2050

17093

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4997

47663

1.99

25.72

12.7

10.5

27.33

27.03

u/l

0.48

4901

46580

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2121

17402

1.37

25.41

6.7

6.4

1.21

mmol/l

0.77

1947

16231

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1019

7359

1.48

25.33

2.6

2.8

2.42

2.43

mmol/l

1.13

916

6618

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1201

8962

1.44

25.12

1.4

1.3

20.98

25.97

iu/ml

1.20

331

2560

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2859

24620

1.35

24.80

3.6

3.2

91.21

97.52

ug/l

1.50

2702

23400

(3035350) Ketones [Presence] in Urine by Test strip

2835

24396

1.35

24.63

4.0

3.5

5.94

4.78

estimate

0.10

505

5129

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1335

10197

1.41

24.42

1.9

1.8

0.81

1.07

mg/l

3.77

973

7595

(3013139) Helicobacter pylori Ag [Presence] in Stool

501

3114

1.67

24.01

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2562

21797

1.34

23.57

5.8

6.2

10.93

11.08

umol/l

0.27

2412

20753

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4468

41565

1.50

23.52

4.9

4.3

5.80

5.76

mmol/l

1.23

4167

38967

(36660697) Celiac disease serology panel - Serum

647

4306

1.57

23.45

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

736

5057

1.53

23.10

2.5

2.7

6.32

7.15

umol/l

0.67

612

4402

(3024561) Albumin [Mass/volume] in Serum or Plasma

2155

17906

1.35

23.05

4.8

5.0

37.14

36.64

g/l

4.14

1995

16895

(3023103) Potassium [Moles/volume] in Serum or Plasma

4698

44221

1.59

23.02

17.6

14.5

3.94

mmol/l

0.63

4594

43207

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

639

4273

1.56

22.64

2.8

2.5

78.78

49.41

u/l

0.26

548

3627

(3019550) Sodium [Moles/volume] in Serum or Plasma

4685

44100

1.58

22.61

17.4

14.4

139.60

139.63

mmol/l

0.38

4596

43191

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1523

12027

1.38

22.50

2.5

2.2

246.96

215.45

u/l

0.29

1428

11467

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1100

8246

1.42

22.03

1.4

1.3

8.97

8.69

u/ml

0.05

398

3380

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5169

50207

2.83

21.55

25.2

20.0

90.41

90.23

2.26

5138

49823

(3035941) MCH [Entitic mass]

5169

50210

2.82

21.49

25.2

19.9

30.20

30.16

1.18

5139

49826

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5169

50212

2.82

21.45

25.7

20.4

41.94

41.42

0.25

5138

49806

(3026361) Erythrocytes [#/volume] in Blood

5169

50216

2.81

21.37

25.2

20.0

4.58

4.57

e12/l

0.90

5088

49315

(3007461) Platelets [#/volume] in Blood

5167

50191

2.78

21.29

25.3

20.1

255.90

256.73

e9/l

0.45

5103

49374

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4977

47681

1.83

21.23

19.3

15.8

74.40

73.91

umol/l

0.50

4931

47179

(3010813) Leukocytes [#/volume] in Blood

5169

50225

2.80

21.19

25.3

20.1

6.77

6.72

e9/l

0.87

5094

49302

(3000963) Hemoglobin [Mass/volume] in Blood

5169

50231

2.80

21.08

25.4

20.2

137.47

136.98

g/l

1.81

5140

49848

(3037522) Nuclear Ab [Titer] in Serum

947

6969

1.44

20.88

1.5

1.4

387.32

513.15

titre

2.48

164

1407

(3015377) Calcium [Moles/volume] in Serum or Plasma

1690

13807

1.33

19.32

2.8

3.3

2.35

mmol/l

0.57

1528

12751

(3026493) Urate [Moles/volume] in Serum or Plasma

1356

10776

1.35

18.55

2.7

2.5

330.22

332.55

umol/l

0.39

1197

9765

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

981

7417

1.40

18.30

4.3

3.5

299.58

472.85

ng/l

0.84

656

4930

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1417

11386

1.33

17.87

2.4

2.3

2.60

2.64

mg/l

0.26

1183

9924

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1207

9479

1.35

17.71

3.1

928.02

1015.71

ng/l

0.44

972

7871

(3013826) Glucose [Moles/volume] in Serum or Plasma

2831

24980

1.29

17.68

5.2

4.9

6.51

6.49

mmol/l

0.17

2664

23205

(3003327) Ova and parasites identified in Stool by Light microscopy

329

1992

1.70

17.32

1.8

1.7

—

(40768797) Stomach Pathology biopsy report

780

5742

1.42

16.85

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

466

3116

1.54

16.33

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

316

1924

1.68

16.30

1.7

12.53

12.19

u/ml

0.04

539

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4670

44445

1.46

15.92

5.5

4.8

2.74

2.78

mmol/l

2.63

4423

42240

(3014111) Lactate [Moles/volume] in Serum or Plasma

510

3497

1.51

15.88

6.9

8.3

1.27

1.31

mmol/l

0.33

494

3430

(3026008) Bacteria identified in Urine by Culture

1465

11994

1.31

15.80

3.2

2.7

—

(3000850) Epithelial cells [#/volume] in Urine

1160

9217

1.33

15.43

3.1

2.6

5.45

6.63

e6/l

1.98

1031

8336

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

463

3141

1.52

15.15

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1738

14630

1.28

14.95

2.5

2.1

—

(3018418) pH of Serum or Plasma

1419

11642

1.30

14.89

4.5

4.0

7.40

0.94

956

8158

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

466

3181

1.51

14.80

1.3

26.97

48.66

au/ml

1.87

196

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

495

3425

1.49

14.73

2.6

2.4

15.05

19.32

au/ml

1.01

423

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

854

6520

1.37

14.70

3.1

2.9

0.60

0.72

ug/l

4.05

510

3736

(3022948) Iron [Moles/volume] in Serum or Plasma

916

7085

1.35

14.49

2.5

13.79

14.13

umol/l

0.71

856

6650

(3022145) Colonoscopy Study observation

664

4874

1.41

14.44

1.5

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4290

40397

1.34

14.36

20.7

16.4

333.16

333.39

g/l

0.96

4269

40175

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1854

15794

1.27

14.30

3.4

3.2

30.31

33.06

u/l

1.32

1753

15009

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4625

44103

1.41

14.02

4.8

4.4

4.60

4.67

mmol/l

5.71

4393

42094

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

868

6709

1.35

13.73

2.7

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1598

13436

1.27

13.57

2.9

2.6

58.01

64.36

u/l

0.52

1456

12551

(3009508) Creatinine [Moles/volume] in Urine

1661

14043

1.27

13.44

3.8

3.5

7.86

8.22

mmol/l

2.26

1425

12259

(3023420) DNA double strand Ab [Units/volume] in Serum

318

2040

1.59

13.34

1.8

2.0

7.69

7.15

iu/ml

0.12

509

(3017143) Hepatitis C virus Ab [Presence] in Serum

983

7769

1.33

13.34

1.8

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

346

2272

1.56

13.13

1.5

1.4

—

(1002224) Polysomnography panel

402

2734

1.51

12.98

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

812

6273

1.35

12.82

2.2

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

358

2385

1.54

12.73

3.9

4.5

24.29

24.14

mmol/l

0.44

351

2360

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4381

41551

1.33

12.67

4.1

3.8

1.30

1.27

mmol/l

1.77

4105

39280

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

200

1152

1.77

12.64

2.0

1.4

5.30

7.78

iu/ml

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4595

43912

1.37

12.48

4.8

4.3

1.42

1.44

mmol/l

4.37

4351

41740

(3026782) Osmolality of Urine

990

7906

1.31

12.37

3.0

2.7

540.08

540.70

mosm/kgh2o

0.03

852

6894

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

772

5953

1.35

12.30

2.6

23.25

23.87

0.63

714

5562

(3005322) IgE [Units/volume] in Serum or Plasma

496

3555

1.44

12.25

1.4

1.3

195.67

242.68

u/ml

0.66

468

3307

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

172

957

1.82

12.22

1.9

2.3

0.00

g/l

-0.00

152

843

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

238

1454

1.67

12.16

1.4

1.3

53.93

42.33

u/ml

—

(3042936) Bacteria identified in Isolate by Culture

763

5886

1.35

12.12

2.2

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

182

1034

1.79

12.07

1.7

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

205

1207

1.73

12.02

1.4

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

161

893

1.83

11.57

2.0

2.3

0.00

g/l

-0.00

152

842

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

267

1701

1.60

11.56

1.4

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

829

6517

1.32

11.53

2.5

2.38

2.39

g/l

0.29

762

6062

(3000991) Gas panel - Venous blood

476

3426

1.43

11.48

8.4

9.5

—

(3023368) Bacteria identified in Blood by Culture

1254

10426

1.27

11.30

4.6

4.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

221

1352

1.66

11.26

1.4

1.3

3.23

5.89

u/ml

0.47

120

(3012516) Albumin [Mass/volume] in Urine

1383

11637

1.26

11.25

3.8

3.6

44.16

54.69

mg/l

1.03

851

7679

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

323

2164

1.52

11.21

1.9

1.6

—

(3019309) Folate [Moles/volume] in Red Blood Cells

742

5767

1.33

11.15

1.7

1073.00

1154.46

nmol/l

1.66

533

4450

(40758558) Short blood count panel - Blood

1542

13153

1.24

11.08

7.2

6.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

220

1356

1.65

10.90

1.4

1.3

5.27

11.37

u/ml

1.30

187

(3020682) Albumin/Creatinine [Ratio] in Urine

1396

11794

1.25

10.89

4.5

4.3

7.57

9.67

mg/mmol

1.07

851

7640

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1006

1.74

10.64

2.0

2.3

0.00

0.02

g/l

0.99

159

912

(3032080) INR in Blood by Coagulation assay

1955

17157

1.22

10.61

10.7

11.3

1.16

1.18

inr

1.13

1622

14218

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

184

1091

1.71

10.56

1.4

1.3

1.47

3.58

u/ml

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

204

1256

1.65

10.17

1.9

2.3

2.89

2.91

g/l

0.11

188

1158

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4164

39508

1.26

10.12

20.3

16.0

13.37

13.38

0.24

4123

38996

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

191

1158

1.67

10.11

2.0

2.4

0.17

0.95

g/l

6.94

172

1012

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1007

8253

1.27

10.08

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1276

10751

1.25

10.07

4.9

4.6

1.80

2.17

ug/l

1.68

1165

9841

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

321

2198

1.49

10.05

8.6

10.7

24.32

24.17

mmol/l

0.34

314

2162

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

187

1132

1.68

9.96

1.8

2.4

10.27

10.35

g/l

0.09

169

1029

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

709

5567

1.32

9.85

2.7

2.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

666

5188

1.32

9.79

1.6

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1290

10933

1.24

9.58

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

581

4469

1.34

9.31

2.3

13.16

13.08

nmol/l

0.08

523

4110

(3052851) Hemolysis interference index of Serum or Plasma

181

1107

1.66

9.29

2.6

2.8

1.99

1.83

index

0.15

591

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1319

1.60

9.24

1.9

2.3

3.75

3.72

g/l

0.08

192

1222

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1320

1.60

9.21

1.9

2.3

4.23

4.24

g/l

0.12

191

1222

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

903

7378

1.27

9.20

1.9

1.8

1.43

1.41

0.30

792

6624

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1321

1.60

9.18

1.9

2.3

7.21

7.30

g/l

0.30

191

1223

(3021589) Normoblasts [#/volume] in Blood

2287

20585

1.20

9.06

11.4

10.3

0.00

e9/l

1.08

1802

16831

(3005719) IgG [Mass/volume] in Serum or Plasma

491

3702

1.36

8.97

2.9

2.7

10.37

10.64

g/l

0.84

453

3431

(3014576) Chloride [Moles/volume] in Serum or Plasma

662

5214

1.31

8.96

6.9

7.6

104.56

104.61

mmol/l

0.10

662

5209

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

388

2817

1.41

8.91

1.8

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1026

8546

1.25

8.83

4.2

3.8

21.56

21.67

0.07

398

3589

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

341

2.16

8.66

4.2

4.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

182

1136

1.62

8.65

1.2

44.59

39.15

u/ml

0.17

100

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

583

4543

1.32

8.52

2.1

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

480

1.95

8.44

1.5

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

426

3172

1.37

8.42

3.3

3.6

4.70

4.69

kpa

0.06

410

3073

(3000570) Elastase.pancreatic [Mass/mass] in Stool

186

1176

1.60

8.40

1.3

1.4

319.94

290.40

ug/g

0.99

104

638

(3002032) Base excess in Venous blood by calculation

485

3687

1.35

8.40

4.0

4.2

1.64

1.71

mmol/l

0.15

428

3204

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

129

741

1.76

8.36

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

129

741

1.76

8.36

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

197

1264

1.58

8.36

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

472

3576

1.35

8.36

1.4

19.45

21.35

iu/l

0.72

403

3012

(3005988) Vibrio sp identified in Specimen by Organism specific culture

482

1.95

8.35

1.5

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2027

18140

1.19

8.34

1.9

1.8

1.42

1.39

mmol/l

0.75

1778

15815

(3025468) Yersinia sp identified in Specimen by Organism specific culture

477

1.95

8.25

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

514

1.90

8.16

1.5

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

350

2540

1.40

8.08

2.2

2.0

—

(3033099) Centromere Ab [Titer] in Serum

3.18

8.06

1.1

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

223

2.39

8.06

2.0

2.3

9.49

9.09

mg/l

0.21

195

(42529406) Shigella sp [Presence] in Stool by Culture

197

1277

1.56

8.01

1.3

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

504

1.90

7.98

1.5

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

746

6071

1.27

7.77

2.1

2.3

29.09

29.42

1.07

728

5892

(3021447) Carbon dioxide [Partial pressure] in Venous blood

493

3800

1.33

7.77

4.0

4.1

5.89

5.83

kpa

0.71

477

3689

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

112

632

1.79

7.74

1.3

1.2

12.80

24.27

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

211

1400

1.53

7.74

1.4

1.3

110.00

85.04

titre

0.65

139

(3014765) Yersinia sp identified in Stool by Organism specific culture

195

1273

1.55

7.70

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

505

1.88

7.61

1.5

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

806

6637

1.25

7.59

3.7

3.6

0.83

0.82

mmol/l

0.31

753

6309

(3034770) Mitochondria Ab [Titer] in Serum

205

1360

1.53

7.54

1.4

1.3

112.00

959.09

titre

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

550

4330

1.30

7.44

2.1

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

1632

14458

1.19

7.29

2.4

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

146

903

1.63

7.26

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

258

1817

1.44

7.07

2.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

219

1495

1.49

7.05

1.2

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

222

1523

1.48

6.97

1.4

1.3

—

(3025941) Bacteria identified in Stool by Culture

377

2841

1.35

6.93

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

521

4116

1.30

6.87

1.3

1.2

135.81

144.35

u/ml

0.18

175

1562

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1638

14577

1.18

6.85

3.6

3.2

97.51

100.43

ng/l

0.01

899

8348

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

490

3842

1.30

6.84

2.3

2.4

0.23

0.22

g/l

1.55

440

3600

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

371

2796

1.35

6.82

4.1

86.25

81.93

ng/l

0.34

323

2495

(3011288) Drugs identified in Urine by Screen method Nominal

368

2770

1.35

6.82

3.6

2.9

—

(3002256) Pathology report gross observation

687

5626

1.25

6.75

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

420

1.89

6.66

1.3

1.2

63.57

60.37

u/ml

—

(3012544) pH of Venous blood

488

3842

1.30

6.60

4.0

4.1

7.37

7.38

0.74

259

2156

(3023410) Appearance of Cerebral spinal fluid

552

1.77

6.58

1.3

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

404

3104

1.33

6.53

2.5

2.2

—

(3019225) pH of Specimen

446

3481

1.31

6.44

4.0

3.8

7.36

7.35

0.48

293

2554

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

246

1752

1.42

6.37

1.6

0.77

4.84

iu/ml

0.49

295

(3024928) Oxygen saturation in Venous blood

158

1032

1.55

6.30

2.6

3.7

63.31

62.89

0.09

148

1002

(3009445) Proteinase 3 Ab [Units/volume] in Serum

246

1759

1.42

6.24

1.5

1.6

21.31

14.74

iu/ml

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

569

4605

1.26

6.18

4.5

4.2

32.00

31.81

0.14

364

3287

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1349

11907

1.18

6.10

1.9

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

329

2482

1.35

6.03

2.8

2.9

142.23

156.44

ng/l

0.41

286

2217

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

208

1453

1.45

6.00

1.1

3.16

5.14

eliau/ml

0.66

210

(44816559) Phosphatidylethanol [Mass/volume] in Blood

337

2556

1.34

5.97

1.8

0.28

0.29

mg/l

0.09

144

1200

(3003458) Phosphate [Moles/volume] in Serum or Plasma

628

5169

1.24

5.89

6.3

6.4

1.04

1.05

mmol/l

0.20

573

4852

(3020961) Endomysium IgA Ab [Titer] in Serum

356

2728

1.33

5.88

1.2

1.1

197.65

163.49

titre

0.08

(3048929) Epstein Barr virus Ab [Presence] in Serum

318

2397

1.35

5.87

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

142

2.47

5.84

1.1

1.0

—

(3017354) Segmented neutrophils/Leukocytes in Blood

375

1.88

5.82

3.1

3.3

58.98

56.56

0.46

334

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

266

1958

1.38

5.72

2.3

2.0

37.92

39.41

u/l

0.65

240

1798

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

531

4304

1.26

5.70

5.7

5.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

367

2840

1.31

5.66

2.2

2.7

67.31

67.03

g/l

0.34

337

2647

(3004616) Nuclear Ab [Presence] in Serum

558

1.70

5.56

1.5

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

195

1367

1.44

5.55

2.6

2.3

299.06

374.88

ug/l

0.40

179

1279

(3028026) IgM [Mass/volume] in Serum or Plasma

368

2858

1.31

5.54

1.9

1.17

1.33

g/l

2.23

331

2667

(3036481) Cortisol [Moles/volume] in Serum or Plasma

565

4630

1.25

5.51

2.3

2.2

382.52

380.80

nmol/l

0.06

517

4298

(3027945) Reticulocytes/Erythrocytes in Blood

512

4149

1.26

5.51

2.5

2.8

1.72

1.75

0.35

448

3737

(3024980) IgG subclass 4 [Mass/volume] in Serum

130

845

1.55

5.36

1.5

1.7

0.70

0.73

g/l

0.13

106

667

(3018333) Ribosomal P Ab [Presence] in Serum

379

1.83

5.34

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

350

2719

1.31

5.27

2.4

2.2

9.82

7.47

ug/l

0.59

300

2431

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

545

1.68

5.24

2.2

2.8

—

(3045414) Leukocytes [Presence] in Urine

495

4020

1.26

5.23

2.2

2.0

0.04

0.02

estimate

0.38

938

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

409

3248

1.28

5.21

2.9

3.6

4.52

4.57

pmol/l

0.59

362

2952

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

391

1.80

5.14

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

134

2.40

5.04

1.5

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

140

941

1.50

4.97

1.7

15577.95

11131.63

e6/l

0.52

660

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

381

1.80

4.96

1.3

261.88

177.92

titre

0.35

(3049717) Cytology report of Urine Cyto stain

163

1132

1.45

4.92

2.3

2.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1071

9422

1.17

4.92

2.1

1.9

—

(3004809) Band form neutrophils/Leukocytes in Blood

579

1.63

4.88

3.5

1.26

1.52

0.48

530

(3017732) Neutrophils [#/volume] in Blood

686

5808

1.21

4.88

3.4

3.0

4.29

4.56

e9/l

0.59

565

5178

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

393

1.77

4.78

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.88

4.75

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

536

4441

1.23

4.73

4.0

4.6

226.14

236.94

u/l

1.53

512

4225

(40759836) Histone Ab [Presence] in Serum by Immunoblot

409

1.75

4.73

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

158

1100

1.45

4.72

3.0

2.6

—

(3016879) Cocaine [Presence] in Urine

451

3669

1.25

4.71

2.5

2.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

463

1.69

4.68

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

152

2.24

4.65

1.8

1.7

—

(3003396) Base excess in Arterial blood by calculation

505

4170

1.23

4.61

7.6

8.5

0.80

0.73

mmol/l

0.18

424

3383

(3000764) Benzodiazepines [Presence] in Urine

480

3942

1.24

4.61

2.4

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

221

1642

1.36

4.55

3.4

2.9

—

(3019977) pH of Arterial blood

508

4205

1.23

4.53

7.6

8.6

7.41

0.07

254

2263

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

122

814

1.51

4.52

1.0

1.1

2.74

2.88

eliau/ml

0.05

425

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

408

1.73

4.50

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

409

1.72

4.46

1.2

—

(3027008) Opiates [Presence] in Urine

481

3966

1.23

4.46

2.4

2.0

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

150

1048

1.44

4.43

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

507

4207

1.23

4.42

7.6

8.5

5.15

5.08

kpa

1.15

492

4057

(3030981) Hyaline casts [#/volume] in Urine by Automated count

392

3162

1.26

4.42

2.7

2.4

0.35

0.41

e6/l

0.31

376

2991

(3028300) Cannabinoids [Presence] in Urine

481

3976

1.23

4.36

2.5

2.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

506

4207

1.22

4.33

7.6

8.5

12.17

13.05

kpa

3.51

491

4057

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

421

1.70

4.31

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

186

1359

1.38

4.27

2.5

1.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

150

1057

1.43

4.24

1.2

1.1

16.14

15.00

au/ml

0.09

307

(3027944) Amphetamines [Presence] in Urine

473

3916

1.23

4.23

2.3

2.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

370

2983

1.26

4.20

1.6

1.7

360.45

298.86

mu/l

0.35

340

2694

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

104

683

1.53

4.18

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

128

880

1.47

4.13

2.3

3.4

1.75

3.27

ratio

1.41

506

(3022621) pH of Urine by Test strip

435

3579

1.23

4.13

2.5

2.4

6.09

6.13

0.45

250

2264

(3034274) Bile acid [Moles/volume] in Serum --fasting

161

1157

1.40

4.09

2.0

2.4

4.15

5.72

umol/l

2.27

112

859

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2278

21308

1.12

4.06

2.8

2.7

—

estimate

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1030

9159

1.15

4.05

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

114

772

1.49

3.98

1.6

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

201

1506

1.35

3.97

2.5

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.54

3.96

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

230

1759

1.32

3.95

1.4

1.3

—

(3013512) EKG study

1376

12501

1.14

3.95

3.4

3.1

0.60

0.76

—

(3016502) Oxygen saturation in Arterial blood

448

3716

1.22

3.94

7.8

9.0

95.34

96.06

1.45

435

3599

(3002619) Bacteria identified in Specimen by Culture

112

2.33

3.91

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1267

11462

1.14

3.87

5.1

4.3

—

(3022313) Gas panel - Capillary blood

226

1732

1.32

3.84

4.4

3.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

912

8081

1.16

3.75

1.6

1.7

65816758.08

35012620.32

pmol/l

0.60

784

6969

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

217

1.90

3.67

1.4

13.00

25.35

u/ml

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.86

3.62

2.2

3.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

139

1000

1.40

3.56

2.6

3.5

34.10

55.15

mg/l

0.91

122

861

(3034860) Kappa light chains.free [Mass/volume] in Serum

139

1000

1.40

3.56

2.6

3.5

42.25

57.93

mg/l

0.99

123

861

(3045424) Erythrocytes [Presence] in Urine

264

2090

1.28

3.54

2.3

2.0

0.04

0.36

estimate

0.45

731

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

257

2029

1.28

3.52

1.9

41.87

38.64

nmol/l

0.94

248

1983

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

481

1.57

3.42

1.2

1.1

229.54

247.03

mg/l

0.50

423

(3023419) Bacteria identified in Sputum by Culture

451

1.58

3.37

3.6

2.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

499

1.55

3.36

1.2

1.1

30.30

39.51

mg/l

3.26

417

(3015171) Extractable nuclear Ab [Units/volume] in Serum

243

1918

1.28

3.35

1.3

0.21

0.96

u/ml

1.98

137

(3004716) Salmonella sp identified in Stool by Organism specific culture

356

2936

1.23

3.35

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

192

1469

1.32

3.34

1.3

1.2

4.26

4.19

0.04

245

(3023511) Choriogonadotropin [Units/volume] in Urine

238

1875

1.28

3.33

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

311

2532

1.24

3.30

4.2

3.6

5.18

5.14

kpa

0.47

292

2444

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1986

18589

1.11

3.29

3.7

3.3

1.22

0.03

estimate

0.50

418

4253

(3001019) Free T4 and TSH panel - Serum or Plasma

380

3167

1.22

3.23

1.7

—

(3036489) Thrombin time

236

1866

1.28

3.22

2.1

2.3

20.62

20.77

0.21

209

1618

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.51

3.20

1.0

0.01

u/ml

0.55

(3016650) Hepatitis A virus Ab [Presence] in Serum

125

902

1.40

3.19

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1507

13922

1.12

3.17

3.2

2.9

1.35

0.04

estimate

0.88

410

4118

(3045683) HLA typing for celiac disease panel - Blood or Tissue

357

1.63

3.15

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

368

3068

1.21

3.13

2.2

2.8

72.43

70.63

e9/l

0.50

248

2196

(3025130) Human papilloma virus identified in Specimen

133

974

1.37

3.11

1.8

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

103

724

1.43

3.06

7.0

5.8

376.44

368.50

umol/l

0.22

645

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

1004

1.36

3.04

7.2

5.4

185.45

831.45

iu/ml

2.02

121

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

214

1688

1.28

3.00

1.8

1.9

1.52

1.44

g/l

0.63

180

1468

(3009214) Lutropin [Units/volume] in Serum or Plasma

277

2253

1.24

3.00

1.4

8.16

8.70

u/l

0.40

215

1815

(3009343) pH of Capillary blood

300

2463

1.23

2.98

4.3

3.6

7.41

0.29

245

2046

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

114

821

1.40

2.97

1.7

1.8

1493.33

2080.00

titre

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

234

1.76

2.95

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

141

1.99

2.94

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

141

1.99

2.94

1.1

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

198

1.82

2.93

1.1

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

146

1098

1.34

2.91

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

122

892

1.38

2.91

2.6

3.4

64.16

62.72

0.34

122

887

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

264

2144

1.24

2.91

4.1

3.5

1.67

1.55

mmol/l

0.22

178

1569

(1617658) Protocol used for examination of sentinel lymph nodes

278

0.36

2.90

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

414

3529

1.19

2.80

8.3

9.4

124.09

123.47

g/l

0.23

407

3456

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.55

2.78

3.2

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

142

1074

1.33

2.74

1.3

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

403

1.54

2.73

1.8

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

196

1.79

2.71

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

204

1.77

2.68

1.1

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

177

1385

1.29

2.68

4.7

3.8

24.71

24.66

mmol/l

0.09

162

1299

(4027681) Cerebrospinal fluid IgG ratio and IgG index

390

1.54

2.66

1.2

0.60

0.64

ratio

0.25

229

(3008536) Aspergillus sp Ab [Presence] in Serum

2.39

2.63

1.5

2.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

122

909

1.35

2.62

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

402

1.52

2.55

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

188

1495

1.27

2.52

1.7

1.9

0.24

0.23

g/l

0.77

180

1423

(4146454) Self-monitoring of blood glucose

364

1.54

2.50

2.8

2.6

—

(44813793) Dust mix specific IgE antibody measurement

389

1.52

2.47

1.1

1.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

180

1.78

2.46

24.8

26.7

127.77

117.24

ug/l

0.34

146

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

193

1545

1.26

2.46

1.7

1.9

1.21

1.18

g/l

0.75

185

1478

(3051611) Lipemic interference index of Serum or Plasma

343

1.55

2.42

2.2

3.0

16.79

13.28

index

0.56

223

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

344

1.55

2.39

1.5

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

302

2542

1.20

2.39

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

112

837

1.35

2.39

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

112

837

1.35

2.39

2.2

3.0

32.08

34.97

umol/l

0.79

100

775

(3020779) Urea [Moles/volume] in Serum or Plasma

397

3425

1.17

2.37

8.6

8.1

8.68

8.56

mmol/l

0.12

381

3314

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

361

1.53

2.37

1.1

—

0.62

—

(4024509) Urine culture

228

1869

1.23

2.36

2.0

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.03

2.35

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

762

6887

1.12

2.32

1.9

1.8

3.43

3.51

ratio

0.99

546

5086

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

670

1.38

2.32

1.1

1.45

1.47

g/l

0.19

610

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

130

999

1.31

2.30

1.5

—

(3037756) Immunofixation for Serum or Plasma

612

1.40

2.29

1.6

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

161

1274

1.27

2.28

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

161

1276

1.27

2.26

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

146

1143

1.29

2.26

1.3

1.5

7.59

30.60

e6/l

2.15

834

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

306

2595

1.19

2.25

1.5

1.14

1.22

ratio

0.70

179

1586

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

306

2595

1.19

2.25

1.5

0.91

0.94

ratio

1.16

178

1573

(3000060) B lymphocytes [#/volume] in Blood

171

1.76

2.24

2.1

2.3

0.23

0.21

e9/l

0.15

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

235

1945

1.22

2.24

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

305

2588

1.19

2.23

1.5

1.17

1.15

ratio

0.10

177

1566

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

432

1.46

2.22

1.3

5.86

5.98

umol/l

0.08

386

(3014271) Vancomycin [Susceptibility]

114

1.93

2.20

4.2

2.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

459

1.44

2.17

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

560

1.40

2.16

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

246

2055

1.21

2.14

1.6

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

147

1161

1.27

2.14

1.4

1.5

405.70

4354.35

e6/l

0.64

106

908

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

197

1611

1.23

2.12

1.1

1.34

2.23

u/ml

1.29

108

855

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

170

1368

1.25

2.12

1.2

—

45.73

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

708

1.35

2.10

2.1

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.21

2.10

1.4

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

421

1.45

2.10

2.3

2.0

15.01

22.82

mg/l

1.90

155

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

438

1.44

2.09

1.9

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

258

2171

1.20

2.09

1.5

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

150

1192

1.27

2.08

1.6

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.14

2.08

1.1

0.44

0.70

umol/24h

—

(3005033) Fetal Nuchal fold Thickness US

247

2074

1.20

2.05

1.4

1.5

1.25

0.01

185

1507

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

183

1491

1.24

2.05

2.0

199.67

207.21

pmol/l

0.37

175

1418

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

193

0.41

2.03

1.4

1.3

102.75

68.17

ug/l

—

193

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

140

1107

1.27

2.03

1.5

1.4

144.39

146.62

au/ml

0.08

315

(3003694) ABO and Rh group [Type] in Blood

1653

15620

1.09

2.03

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

176

1430

1.24

2.03

1.7

2.2

3.74

7.33

iu/l

0.48

640

(3020911) Cortisol [Moles/time] in 24 hour Urine

185

1.68

2.00

1.5

1.4

149.41

271.19

nmol/24h

0.35

185

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

271

1.55

2.00

1.8

1.6

6.16

4.84

nmol/l

0.10

212

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

224

1.61

1.99

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

485

1.41

1.98

1.2

1.1

15.53

16.51

u/ml

0.15

210

(3020717) Zinc [Moles/volume] in Serum or Plasma

336

1.49

1.98

1.5

1.6

21.83

22.14

umol/l

0.03

308

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

445

1.42

1.94

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

321

2772

1.17

1.94

1.5

59.36

60.52

ug/l

0.19

265

2331

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

338

1.48

1.93

2.5

2.8

199.36

209.98

e6/l

0.16

279

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

330

1.49

1.93

2.0

2.7

606.88

540.79

e6/l

0.30

260

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

290

1.52

1.92

1.1

8.52

4.78

nmol/l

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

184

1513

1.22

1.91

2.4

2.7

177.14

179.21

0.13

171

1439

(3010144) Erythrocytes [#/volume] in Synovial fluid

323

1.49

1.90

1.7

1.4

50454.66

93871.56

e6/l

0.35

223

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

583

5253

1.12

1.90

1.7

1.6

3.32

3.45

mmol/l

2.11

370

3484

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

171

0.41

1.90

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

117

914

1.29

1.89

2.3

2.2

134.24

132.30

g/l

0.38

742

(21494755) Public health laboratory ask at order entry panel

696

6336

1.11

1.89

1.3

—

(40757373) Influenza virus identified in Isolate

2.16

1.87

2.7

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

144

1156

1.25

1.87

1.4

3.88

3.67

mmol/l

1.06

137

1098

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1.55

1.86

1.3

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

391

1.44

1.85

2.0

1.6

—

(37208534) Antinuclear antibody arbitrary concentration in serum

159

1.70

1.85

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

250

2127

1.18

1.83

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

570

1.36

1.82

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

248

2109

1.18

1.82

1.5

1.7

3.82

4.40

mg/l

0.34

179

1513

(3007919) Fasciola sp Ab [Titer] in Serum

4.17

1.82

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

138

1107

1.25

1.81

1.1

4.40

5.70

u/ml

0.41

508

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

287

1.50

1.79

1.6

1.4

7.33

6.63

u/l

0.16

249

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

328

1.47

1.78

2.0

1.9

2.69

1.95

u/ml

0.19

109

(3008757) Leukocyte morphology finding [Identifier] in Blood

353

1.45

1.78

3.4

3.9

—

(4015189) Microbial culture of sputum

2.17

1.77

4.0

1.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.17

1.77

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

172

1418

1.22

1.77

1.1

5.40

6.13

u/ml

0.22

795

(3024139) IgG subclass 3 [Mass/volume] in Serum

514

1.37

1.75

1.2

1.4

0.33

0.38

g/l

0.91

372

(3028192) IgG subclass 2 [Mass/volume] in Serum

514

1.37

1.75

1.2

1.4

2.60

2.98

g/l

1.61

375

(3008401) Mugwort IgE Ab [Units/volume] in Serum

166

1365

1.22

1.75

1.1

1.73

1.05

u/ml

0.40

607

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.90

1.75

1.3

1.7

0.33

0.27

nmol/l

0.19

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.93

1.74

1.1

1.4

1.17

1.18

mmol/l

0.28

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

102

793

1.29

1.74

1.2

1.1

2.06

2.94

0.71

167

(3027135) IgG subclass 1 [Mass/volume] in Serum

515

1.36

1.74

1.2

1.4

6.10

6.62

g/l

1.09

375

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

178

1.63

1.72

1.0

1.3

109.25

90.63

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

183

1524

1.21

1.71

2.6

2.8

3.59

3.57

g/l

0.09

173

1453

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

274

1.50

1.70

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

118

1.78

1.69

2.2

1.5

—

(4062490) Immunoglobulin typing, IgG

509

1.36

1.69

1.3

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.00

1.69

1.3

16.74

52.49

ng/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

332

0.57

1.68

1.9

2.3

1.18

1.19

mmol/l

0.48

326

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

248

2126

1.17

1.68

9.7

11.2

16.38

16.24

0.36

243

2047

(3011897) Casein IgE Ab [Units/volume] in Serum

111

1.80

1.68

1.3

1.2

0.11

0.29

u/ml

0.70

111

(3035285) Chloride [Moles/volume] in Venous blood

344

0.58

1.67

1.9

2.3

105.45

105.59

mmol/l

0.07

338

(3041354) Potassium [Moles/volume] in Venous blood

344

0.58

1.67

1.9

2.3

4.03

4.02

mmol/l

0.04

338

(3032057) Clostridioides difficile [Presence] in Stool

2.10

1.65

2.2

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

368

1.42

1.63

1.2

1.1

114.75

112.39

pmol/l

0.17

368

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

420

1.39

1.60

1.1

293.35

285.69

mg/l

0.28

384

(40762887) Creatinine [Moles/volume] in Blood

3.00

1.58

1.0

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

163

1356

1.21

1.56

1.1

1.99

1.81

u/ml

0.13

689

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

108

861

1.26

1.54

1.3

5.02

4.40

u/ml

0.14

393

(3006922) Hepatitis E virus Ab [Presence] in Serum

415

1.38

1.54

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

124

1005

1.24

1.54

1.1

0.78

0.23

u/ml

0.62

308

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

764

1.27

1.53

3.0

2.5

61.00

29.71

iu/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

428

3842

1.12

1.53

2.7

2.4

5149.28

6629.73

u/l

0.57

177

1542

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

155

1287

1.21

1.52

1.3

229.66

243.45

u/ml

0.24

810

(3020876) Protein [Mass/time] in 24 hour Urine

442

1.36

1.51

2.1

2.4

1.09

1.53

g/24h

0.60

270

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

185

1.57

1.51

1.1

89.57

90.76

—

(3000093) Morphology [Interpretation] in Blood Narrative

366

1.40

1.50

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

110

882

1.25

1.50

1.3

5.10

3.33

u/ml

0.37

329

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.86

1.50

5.3

3.6

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.16

1.50

2.2

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

1209

1.21

1.48

2.2

11.96

11.15

mg/l

0.56

133

1145

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

401

1.38

1.48

1.3

1.2

3.67

1.92

u/ml

0.39

209

(3014148) Varicella zoster virus Ab [Titer] in Serum

118

956

1.24

1.48

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

410

1.37

1.47

12.3

13.5

0.60

0.61

mmol/l

0.14

376

(3002179) Metamyelocytes/Leukocytes in Blood

412

3702

1.12

1.46

5.0

4.4

0.58

0.65

0.28

126

986

(3020191) Ethanol [Moles/volume] in Serum or Plasma

463

1.34

1.45

2.1

1.5

1.51

1.29

promille

0.54

361

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

352

1.40

1.45

1.2

1.1

0.94

1.07

u/l

2.16

139

(44806118) Parainfluenza type 4 nucleic acid detection

543

1.31

1.42

2.0

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

543

1.31

1.42

2.0

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

543

1.31

1.42

2.0

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

543

1.31

1.42

2.0

1.5

—

(40768441) Liver Pathology biopsy report

312

1.41

1.40

1.3

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

103

1.75

1.40

2.7

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

190

1622

1.18

1.40

2.2

2.5

97.21

94.54

1.07

183

1564

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

212

0.52

1.39

3.8

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

441

1.34

1.38

1.1

0.40

1.80

u/ml

1.02

140

(3011412) CD3 cells [#/volume] in Blood

442

1.34

1.36

2.1

2.6

1306.76

1278.13

e6/l

0.07

379

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

436

1.33

1.32

1.6

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

148

1245

1.19

1.31

1.4

1.5

0.42

0.44

nmol/l

0.16

126

988

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

160

1.57

1.31

2.0

2.2

15.63

14.80

umol/l

0.15

160

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

129

1.63

1.29

2.1

1.8

41.21

41.09

g/l

0.04

129

(3019150) Specific gravity of Urine by Refractometry

1152

10914

1.07

1.28

3.9

3.5

1.02

1.45

kg/l

1.08

744

7083

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

228

2604

0.87

1.28

1.4

1.3

212.11

229.91

miu/ml

0.33

113

1262

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.89

1.28

1.0

1.7

—

5743.75

u/ml

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.94

1.27

1.5

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

2.00

1.27

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

371

1.35

1.25

1.6

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

274

2428

1.14

1.25

1.1

0.64

ratio

0.04

238

(40768446) Kidney Pathology biopsy report

203

1.48

1.24

1.8

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

227

0.57

1.21

3.5

1.4

—

(3024263) Appearance of Synovial fluid

180

1.50

1.20

2.4

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

162

1887

0.85

1.20

1.5

68.62

59.86

ug/l

1.20

162

1887

(3006571) Granulocytes/Leukocytes in Synovial fluid

426

1.32

1.20

1.9

1.7

49.90

54.62

0.42

261

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

374

1.34

1.20

1.6

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

648

0.75

1.18

2.9

7.94

7.34

mmol/l

0.40

628

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

189

2172

0.87

1.18

1.8

—

(3037121) Protein [Mass/volume] in Urine

166

1427

1.17

3.4

1112.55

336.10

mg/l

1.02

662

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

199

0.55

1.17

3.8

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

157

1.53

1.17

1.1

1.4

16.89

16.34

umol/l

0.21

133

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

420

1.31

1.16

1.4

1.42

1.43

nmol/l

0.03

377

(3004119) Hemoglobin [Mass/volume] in Venous blood

257

2282

1.13

1.16

3.2

3.4

133.95

131.87

g/l

0.84

247

2222

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

209

2380

0.87

1.15

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.73

1.15

5.3

6.5

—

501.40

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

103

1.65

1.12

1.6

1.3

0.16

0.27

mmol/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.90

1.12

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

817

1.22

1.11

1.2

1.1

117.55

114.59

0.47

746

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.71

1.11

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

193

1.45

1.08

1.2

1.1

71.70

199.53

ng/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

266

2969

0.89

1.08

3.9

3.4

1.23

mmol/l

0.02

230

2574

(3006653) Thiamine [Moles/volume] in Blood

235

1.41

1.08

1.1

1.4

140.42

130.85

nmol/l

0.59

235

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.19

1.08

1.9

1.6

—

(3044927) Protein electrophoresis panel - Urine

287

1.36

1.06

1.2

1.1

—

(3024932) HLA-DR beta [Type]

145

1.52

1.05

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

145

1.52

1.05

1.2

1.4

125.15

130.00

nmol/l

0.05

105

(3015076) Soybean IgE Ab [Units/volume] in Serum

418

1.29

1.05

1.1

1.0

1.23

1.07

u/ml

0.05

101

(3025159) Blasts/Leukocytes in Blood

415

3808

1.10

1.05

5.7

4.9

0.38

0.17

0.25

107

847

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

111

933

1.19

1.04

1.5

1.6

306.95

356.54

mu/l

0.86

751

(3028679) Herpes simplex virus Ab [Presence] in Serum

366

1.31

1.04

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

332

1.33

1.03

2.5

2.3

—

(3000012) Reticulocyte production index

463

0.73

1.03

1.4

2.0

0.82

0.89

0.49

291

(3024471) HLA-A [Type]

146

1.51

1.03

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

130

1.54

1.02

3.6

2.7

0.62

mmol/l

0.13

130

(3012441) Differential panel - Pleural fluid

298

1.34

1.02

1.3

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

138

1186

1.17

1.01

1.1

3.92

3.90

u/ml

0.01

602

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

189

0.58

1.00

1.5

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.00

1.00

1.9

1.8

—

(40768795) Lymph node Pathology biopsy report

378

1.30

0.99

1.3

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

583

1.24

0.99

1.1

—

50.08

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

317

1.33

0.99

1.9

1.6

41.30

34.63

0.58

192

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

164

1.47

0.99

2.1

2.4

—

(3042631) Mycobacterium sp identified in Specimen

405

1.29

0.98

2.7

2.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.80

0.98

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

154

1339

1.15

0.98

1.4

1.3

4.82

3.55

ug/l

0.28

149

1245

(3028433) Virus identified in Specimen by Culture

124

1.53

0.96

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

165

1.46

0.96

6.3

4.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

310

1.33

0.96

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

310

1.33

0.96

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

310

1.33

0.96

1.8

1.5

—

(4195642) Thrombophilia screening test

823

1.19

0.95

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

403

3715

1.09

0.94

5.4

4.7

0.15

0.12

0.23

107

885

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

268

1.35

0.94

2.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

234

1.37

0.93

1.1

—

(3004775) Volume in Urine collected for unspecified duration

269

0.67

0.93

2.3

2.4

634.42

621.19

0.08

191

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

108

919

1.18

0.92

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1353

13022

1.05

0.90

4.3

3.6

0.01

0.00

estimate

0.20

480

4798

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.07

0.89

1.5

1.7

282.57

622.58

nmol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

359

1.28

0.88

3.4

2.5

20.21

28.96

mg/l

1.22

256

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

211

1.38

0.88

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.87

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.86

0.87

1.1

—

411.50

—

(3006462) Nitrate [Presence] in Urine

186

1.40

0.87

2.9

2.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.00

0.87

1.2

3.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

170

1.41

0.85

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

347

3197

1.09

0.85

2.6

75.58

74.37

ml/min/173m2

0.23

151

1302

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.63

0.84

1.0

0.21

0.73

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.56

0.84

1.4

1.2

42.14

38.65

g/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

357

3295

1.09

0.84

3.4

4.4

8.23

27.60

ug/l

1.13

261

2595

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

123

1068

1.16

0.83

2.2

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

222

1.35

0.83

2.1

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

336

1.28

0.83

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

388

0.75

0.82

1.0

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

625

1.20

0.82

1.3

0.16

0.32

nmol/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

417

1.25

0.82

1.1

8.14

8.20

iu/ml

0.01

120

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

197

1.37

0.82

1.4

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

197

1.37

0.82

1.4

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

138

1.45

0.81

4.0

4.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

544

1.22

0.81

1.5

34.39

38.14

nmol/l

0.40

490

(3017181) Myelocytes/Leukocytes in Blood

414

3852

1.08

0.81

5.4

4.6

0.91

0.89

0.04

117

1020

(3045142) Bone marrow Pathology biopsy report

410

1.25

0.79

1.2

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

447

1.23

0.78

1.1

0.64

2.59

u/ml

0.85

110

(3008295) Osmolality of Serum or Plasma

447

1.23

0.78

1.6

281.97

282.31

mosm/kgh2o

0.03

348

(21494434) Karyotype in Bone marrow

295

1.29

0.78

1.1

1.2

—

(3001729) Color of Synovial fluid

0.00

0.77

0.0

1.5

—

(4211845) Urine protein measurement

208

1.35

0.77

2.9

2.6

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

217

1.34

0.76

1.9

2.6

19.25

162.34

ug/l

0.71

200

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.64

0.75

4.5

3.7

26.40

22.69

mg/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

495

1.21

0.75

1.6

1.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.64

0.73

3.1

2.4

2.67

3.35

mg/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.64

0.73

1.7

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

263

1.29

0.72

2.6

3.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

290

1.28

0.72

1.4

78.16

76.96

umol/l

0.10

290

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

185

1.35

0.71

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.62

0.71

2.1

1.5

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.75

0.71

1.3

1.2

—

(3007463) Buprenorphine [Presence] in Urine

1.75

0.71

1.6

5.9

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.58

0.71

2.7

3.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.58

0.71

1.0

1.1

—

(4212803) Bone marrow aspirate examination

1.92

0.70

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.51

0.69

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.85

0.68

1.4

1.6

45.80

45.48

umol/l

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.60

0.68

1.1

1.0

0.70

1.82

u/ml

—

(1761482) Bacteria [#/volume] in Urine by Culture

726

0.84

0.68

3.8

3.7

—

(3006270) Folate [Moles/volume] in Blood

311

1.26

0.67

1.1

462.06

396.76

nmol/l

1.49

289

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

338

1.24

0.67

2.4

2.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

770

1.16

0.67

1.8

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

140

1250

1.12

0.67

3.1

3.8

258.30

3409.37

u/ml

0.83

115

1094

(4268621) Lupus anticoagulant assay

631

1.18

0.67

2.2

2.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

743

1.16

0.66

1.1

1.2

1.16

0.98

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.79

0.66

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

212

1939

1.10

0.65

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

128

1.41

0.65

1.1

1.2

99.22

96.16

0.19

128

(4034850) Laboratory test

114

1288

0.88

0.65

10.2

8.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

313

1.25

0.64

1.3

1.5

29606.11

79784.04

e6/l

1.16

178

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

100

877

1.14

0.64

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

251

1.28

0.64

1.9

2.4

131.64

148.58

nmol/l

0.37

219

(4198724) Urine methamphetamine measurement

387

1.22

0.62

2.6

3.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.52

0.62

1.5

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.63

0.62

1.6

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

130

1.39

0.61

1.4

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

110

975

1.13

0.61

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

478

0.81

0.60

1.8

24.92

436.99

pmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

413

3899

1.06

0.59

3.2

2.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

473

1.19

0.58

3.6

3.4

0.72

0.80

nmol/l

1.24

382

(3008898) HLA-B27 [Presence]

240

2222

1.08

0.58

1.1

—

(4038314) Semen analysis, post vasectomy

1.56

0.58

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

659

1.16

0.58

1.3

17.25

30.44

u/l

1.47

570

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.00

0.58

0.0

1.5

—

0.38

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.51

0.58

1.7

3.2

—

(3011985) Renin [Units/volume] in Plasma

622

1.16

0.58

1.6

62.58

66.82

mu/l

0.10

559

(3047181) Lactate [Moles/volume] in Blood

1116

0.88

0.57

5.2

6.4

1.30

1.27

mmol/l

0.11

976

(3022229) Phosphate [Moles/volume] in Urine

1.67

0.56

3.0

2.0

15.98

22.07

mmol/l

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.46

0.56

1.0

—

(3034426) Prothrombin time (PT)

172

0.70

0.56

1.2

1.3

29.25

28.78

0.10

172

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

923

0.88

0.55

2.6

2.4

0.98

0.89

nmol/l

0.48

790

(40765096) Chromosome analysis panel by Banding

125

0.64

0.54

1.1

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

321

1.22

0.54

2.3

2.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.58

0.54

1.2

1.5

7.32

28.36

nmol/l

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

1.42

0.54

1.4

1.3

41.50

48.93

0.36

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1110

0.89

0.53

1.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.48

0.53

15.0

10.0

4.37

5.93

mmol/l

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

148

1349

1.10

0.52

2.2

1.9

1.41

1.81

ug/l

0.39

127

1214

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

286

1.23

0.52

1.3

883.33

1008.16

titre

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.43

0.52

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

271

0.77

0.52

2.8

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

950

1.12

0.52

2.0

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

452

1.17

0.51

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

761

1.13

0.51

2.1

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

480

1.17

0.51

2.4

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.50

0.51

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

203

0.74

0.51

2.0

2.1

7.33

8.01

mmol/l

0.38

203

(40761995) Spermatozoa Progressive [#/volume] in Semen

251

1.24

0.51

3.3

3.2

44.81

45.43

0.07

251

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

251

1.24

0.51

6.5

10.16

8.59

0.65

251

(40765089) Chromosome analysis panel - Blood by G-banded

324

1.21

0.50

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.39

0.50

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

791

1.13

0.50

1.7

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

127

1.34

0.49

1.1

—

160.00

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.56

0.49

1.9

1.6

1.11

0.91

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.56

0.49

1.9

1.6

1.07

1.76

mg/l

—

(3007916) DNA double strand Ab [Titer] in Serum

1.56

0.49

1.1

1.4

—

110.38

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.40

0.48

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

1.35

0.48

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

128

1.33

0.47

1.4

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

663

1.13

0.47

2.5

1.6

—

(44806071) Cardiolipin IgM antibody measurement

1.41

0.46

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

664

1.13

0.46

3.0

3.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.40

0.45

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

506

1.15

0.44

2.4

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

497

1.15

0.44

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

151

1393

1.09

0.44

3.7

4.4

1.32

1.36

mg/l

0.29

142

1305

(3010937) Rubella virus Ab [Presence] in Serum

1.37

0.44

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

507

1.15

0.44

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

238

1.22

0.44

5.9

2.1

178.47

174.74

umol/l

0.02

134

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

130

1.31

0.43

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

284

1.20

0.43

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

583

1.13

0.43

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.41

0.43

2.1

1.8

7.62

415632.19

nmol/l

0.72

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

0.43

3.8

6.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

248

1.21

0.42

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

565

1.13

0.42

1.6

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

1.31

0.42

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.52

0.41

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

156

1447

1.08

0.41

1.2

1.3

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.41

0.0

1.3

—

6112.00

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

33.35

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

114

1.32

0.40

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

133

1440

0.92

0.40

4.3

5.7

0.85

0.88

0.48

127

1358

(3041806) Other cells [#/volume] in Blood by Manual count

380

1.16

0.40

1.5

0.52

e9/l

0.00

380

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.02

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

12.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

1.31

0.39

6.4

10.9

0.33

0.40

umol/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.34

0.39

1.2

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.43

0.39

1.2

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.43

0.39

1.2

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.39

0.0

1.0

—

3.11

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.39

0.0

1.2

—

277.07

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

542

1.13

0.38

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

136

0.73

0.37

1.2

1.6

—

(3044007) Cell count panel - Peritoneal fluid

113

0.71

0.37

1.4

2.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.35

0.37

1.0

1.6

246.80

302.43

umol/24h

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

115

1060

1.09

0.37

2.7

3.8

0.30

0.35

iu/ml

0.81

558

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

110

1012

1.09

0.36

2.2

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.27

0.36

1.6

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

277

0.83

0.35

8.5

7.6

19.88

126.43

ug/l

0.78

187

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

282

1.17

0.35

1.7

—

(1616796) Gas panel - Central venous blood

861

1.09

0.35

3.3

3.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

1.28

0.35

1.3

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

882

1.09

0.34

1.1

52.00

1877.50

iu/ml

0.78

218

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.35

0.31

1.1

123.43

96.00

titre

—

(3044009) aPTT.lupus sensitive (LA screen)

1.35

0.31

1.1

1.2

—

(3012898) Urea [Moles/volume] in Urine

1.32

0.30

2.0

1.8

110.16

183.92

mmol/l

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

193

1.19

0.30

1.9

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

193

1.19

0.30

1.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

193

1.19

0.30

1.9

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

193

1.19

0.30

1.9

1.6

—

(3019174) dRVVT (LA screen)

1.30

0.30

1.1

—

(3017569) Oxygen content in Arterial blood

185

0.81

0.29

2.1

2.5

15.93

16.63

0.35

185

(3023199) Leukocytes [#/volume] in Pleural fluid

363

1.13

0.29

1.3

1.5

2571.28

4223.36

e6/l

0.29

253

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

141

0.78

0.29

1.0

6.36

39.00

iu/ml

6.79

141

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.23

0.29

1.6

—

(40768793) Breast Pathology biopsy report

1002

0.93

0.28

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

270

0.85

0.28

2.4

2.1

2.70

1.78

u/field

—

151

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.28

0.28

1.3

1.1

—

(3004451) EKG impression Narrative

186

1.18

0.27

1.5

1.2

—

(3045788) Cell count panel - Pleural fluid

308

1.14

0.27

1.4

1.5

—

(3018572) Chloride [Moles/volume] in Blood

730

0.92

0.27

5.5

8.1

103.75

105.55

mmol/l

2.36

657

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

678

0.91

0.27

1.4

1.5

—

7.23

—

(3039000) Anion gap in Blood by calculation

729

0.92

0.26

5.4

8.1

11.72

11.42

mmol/l

0.35

656

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.69

0.26

1.6

1.3

5.00

5.57

mmol/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

587

1.09

0.26

1.3

1.4

315.19

346.99

pmol/l

0.31

509

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

160

0.81

0.26

1.4

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

820

1.07

0.25

2.5

63.37

115.44

ug/min

1.08

534

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

149

1569

0.95

0.24

4.1

5.4

1.80

1.68

0.58

143

1481

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

133

1.20

0.24

1.1

5.42

2.12

u/ml

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

303

1.12

0.23

1.3

1.2

8.65

8.19

mm/h

0.09

303

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

190

0.84

0.23

2.1

1.6

1.56

4.43

u/field

—

141

(3035880) pH of Pleural fluid

147

0.82

0.23

1.1

1.4

7.33

7.39

—

100

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

115

1087

1.06

0.22

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

125

1.20

0.22

1.5

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

219

1.14

0.22

1.0

659.20

781.53

ng/l

1.07

146

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

1.21

0.22

2.4

3.3

9.92

10.63

kpa

0.48

116

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

116

1.21

0.22

2.4

3.3

5.03

4.86

kpa

0.12

116

(3000034) Microalbumin [Mass/volume] in Urine

305

1.12

0.21

2.5

3.3

15.24

71.07

mg/l

1.99

232

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.16

0.21

1.0

1.1

1.03

1.65

umol/24h

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

402

1.10

0.20

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

145

1.17

0.20

3.2

2.6

22.84

28.86

umol/l

—

(3003434) Protein [Mass/volume] in Pleural fluid

383

1.10

0.20

1.4

1.6

33.84

33.68

g/l

0.03

343

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.25

0.20

1.1

3.3

3.50

5.47

ug/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

309.29

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.6

—

2.18

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.20

0.0

1.4

—

22.25

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

221

1.13

0.20

1.0

43.73

41.52

ng/l

0.13

145

(3051387) C reactive protein [Mass/volume] in Capillary blood

830

0.94

0.20

3.4

3.2

17.29

24.34

mg/l

2.04

553

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

519

1.08

0.20

1.3

0.17

0.20

nmol/l

0.52

406

(4133840) Spirometry

144

0.83

0.19

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

127

1.18

0.19

4.7

2.5

—

(1761868) Lipid panel - Serum or Plasma

2019

20015

1.01

0.19

2.8

2.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

222

1.13

0.19

1.0

309.25

297.11

ng/l

0.11

151

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

1.24

0.18

1.0

0.01

0.38

u/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

232

1.12

0.18

1.7

1.4

139.65

168.45

mmol/24h

1.31

232

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

764

1.06

0.18

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

217

0.88

0.18

1.1

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

673

0.94

0.18

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.19

0.18

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

119

1.18

0.17

2.6

2.7

71.63

131.04

ng/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

186

1.13

0.17

1.0

1.1

7.41

1.70

u/ml

0.38

111

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.18

0.16

2.1

2.8

377.75

1086.98

u/l

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

398

1.08

0.16

1.6

1.3

1.83

1.97

mmol/l

0.55

374

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

105

1003

1.05

0.16

1.4

19.09

21.57

u/l

0.42

845

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

141

0.85

0.16

2.2

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

141

0.85

0.16

2.2

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

141

0.85

0.16

2.2

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

669

0.94

0.16

3.5

3.8

1031.06

702.37

u/ml

0.14

621

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

264

1.10

0.15

2.6

2.8

40.74

43.42

0.29

133

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

328

0.91

0.15

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

244

0.90

0.14

1.0

1.1

88.88

93.24

0.35

194

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

353

1.08

0.14

1.2

1.1

1.05

ratio

0.07

289

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

500

1.06

0.13

1.3

1.2

—

32.71

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.17

0.13

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

321

3274

0.98

0.12

1.5

1.4

—

(4035726) Immunohistochemistry procedure

334

3276

1.02

0.12

1.5

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

366

1.07

0.11

1.1

1650.08

1466.80

miu/ml

0.59

366

(3040151) Glucose [Moles/volume] in Capillary blood

425

1.06

0.11

5.5

6.3

8.04

6.98

mmol/l

0.63

353

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

270

1.07

0.10

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

249

0.92

0.10

1.5

1.8

0.62

1.35

nmol/l

6.29

185

(3010421) pH of Blood

130

1265

1.03

0.10

3.0

3.5

7.40

7.41

1.52

130

1250

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.14

0.10

1.0

—

(44806420) Estimation of glomerular filtration rate

565

0.96

0.10

2.4

2.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.06

0.09

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

174

1.09

0.09

1.7

1.5

14.06

14.53

pmol/l

0.10

144

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

493

0.95

0.09

5.8

5.1

39.99

90.99

u/ml

0.68

158

(3028271) Lactate [Moles/volume] in Capillary blood

596

1.04

0.09

2.0

1.7

1.52

1.71

mmol/l

0.96

582

(3042517) Benzodiazepines panel - Urine

1.13

0.09

2.8

2.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

165

1.09

0.08

1.6

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.03

0.08

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.81

0.08

1.8

2.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.79

0.08

2.6

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.08

0.08

1.1

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

287

0.94

0.08

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.80

0.07

1.2

1.3

—

7.34

—

(3023383) Lactate [Moles/volume] in Pleural fluid

0.80

0.07

1.5

2.83

3.55

mmol/l

—

(3020650) Glucose [Presence] in Urine

176

1.08

0.07

1.5

1.6

0.32

0.02

estimate

0.73

176

(40758292) HTLV I+II Ab panel - Serum

108

1.11

0.07

1.1

1.3

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

0.82

0.07

1.3

1.5

26.43

26.91

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.06

0.07

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

1.02

0.07

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.85

0.06

1.0

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

177

1.07

0.06

1.7

1.5

1.33

4.63

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

154

1513

1.02

0.06

3.7

3.4

25.24

25.29

mmol/l

0.06

147

1456

(3003181) Sodium [Moles/volume] in Urine

621

1.03

0.06

1.6

1.4

55.49

64.63

mmol/l

1.08

500

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

207

1.06

0.06

1.5

1.2

—

(3012501) Base excess in Blood by calculation

810

1.03

0.06

3.2

3.7

2.11

2.27

mmol/l

0.29

498

(3013290) Carbon dioxide [Partial pressure] in Blood

810

1.03

0.06

3.2

3.7

4.92

4.97

kpa

0.40

795

(40761536) Microorganisms panel - Urine sediment

389

3855

1.01

0.05

4.3

3.5

—

(3027315) Oxygen [Partial pressure] in Blood

811

1.02

0.05

3.2

3.7

9.07

8.95

kpa

0.33

795

(3008152) Bicarbonate [Moles/volume] in Arterial blood

215

2177

0.99

0.05

6.3

7.1

24.62

24.28

mmol/l

0.75

208

2082

(3000330) Specific gravity of Urine by Test strip

189

1865

1.01

0.05

3.1

3.0

1.02

ratio

0.11

169

1657

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

504

5009

1.01

0.04

1.6

947.92

1005.24

mu/l

0.76

421

4261

(3045716) Anion gap in Serum or Plasma by calculation

407

1.03

0.04

3.1

2.9

9.36

10.49

mmol/l

1.84

400

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

233

2308

1.01

0.04

1.8

2.9

26.84

50.68

u/ml

2.73

223

2232

(3017704) Immunofixation for Urine

170

0.94

0.04

2.4

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

170

1.06

0.04

1.1

1.0

—

(3020491) Glucose [Moles/volume] in Blood

358

1.03

0.04

1.6

1.7

7.34

6.20

mmol/l

1.05

271

(40768806) Pleura Pathology biopsy report

289

1.04

0.04

1.4

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

131

1.07

0.03

1.6

1.5

8.63

8.47

ug/l

0.05

131

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

171

1.05

0.03

1.4

2.0

56.40

142.40

ug/min

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

221

1.04

0.03

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

229

0.96

0.02

1.7

1.5

10.82

13.01

u/l

1.39

221

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

138

0.94

0.02

4.7

3.8

0.50

1.35

3.74

138

(21494814) CD8 cells/Lymphocytes in Specimen

168

0.95

0.02

2.0

2.2

25.88

28.65

0.52

168

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

117

0.94

0.01

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

117

0.94

0.01

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

117

0.94

0.01

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

532

1.02

0.01

1.1

—

(3016038) Potassium [Moles/volume] in Urine

243

1.03

0.01

1.7

1.2

34.05

37.07

mmol/l

0.30

225

(3047189) Immunofixation for 24 hour Urine

146

0.96

0.00

1.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

115

0.96

0.00

1.0

1.6

—

0.88

—

(3013637) Mi-2 Ab [Presence] in Serum

125

0.96

0.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

125

0.96

0.00

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

125

0.96

0.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

125

0.96

0.00

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

575

1.01

0.00

2.0

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

184

0.98

0.00

1.9

2.4

86.67

106.47

ng/l

0.62

184

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

133

0.98

0.00

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

344

0.99

0.00

2.0

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

426

1.01

0.00

1.4

199.40

192.06

pmol/l

0.09

426

(3001556) Androgen free Index in Serum or Plasma

1.01

0.00

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

251

1.00

0.00

1.0

10.12

13.60

u/ml

0.31

169

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

291

1.00

0.00

1.3

1.5

5.42

5.41

mmol/l

0.01

280

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

0.26

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

3.2

—

(3028717) Thiamine [Mass/volume] in Blood

0.93

-0.00

1.1

1.3

64.38

64.84

ug/l

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.17

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.0

—

11.67

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

42.20

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

1.25

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.98

-0.00

1.0

0.03

0.09

u/ml

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

240.80

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.92

-0.00

1.0

0.10

5.49

u/ml

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3014.29

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.88

-0.00

1.0

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.02

-0.00

1.4

1.3

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.40

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.90

-0.00

12.7

6.4

0.22

0.20

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.88

-0.00

1.0

1.1

0.03

u/ml

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

0.85

-0.00

2.6

1.2

66.20

59.69

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_SUPERF_MYCOSIS_WIDE – Other superficial mycoses, including avohilmo

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other superficial mycoses, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other superficial mycoses, including avohilmo (AB1_OTHER_SUPERF_MYCOSIS_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints